Neogen share price today
Neogen Corporation · NEOG · Healthcare · Medical Devices · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists
Neogen share price: $12.46 at the close on 4 November 2026, +94.7% in a year.
Neogen Corporation's results are improving, and its P/E is near the top of its own history, higher than 83% of past readings.
The main question: results are strong, and the P/E is higher than 83% of its own history.
The price has been rising for 28 weeks, and the P/E is higher than 83% of its own last 2.6 years. Over the last four quarters, results have been improving, with profit −132.8% on a year earlier, and 137% of the last 2 years' profit came in as cash. What will decide it: whether earnings grow enough to match the multiple.
What is the Neogen share price today?
Neogen Corporation's share price was $12.46 at the close on 4 November 2026. It has been rising for 28 weeks. That is 19.1% above its average price over the last 200 trading days. In the last 52 weeks it traded between $6 and $14, and at that close it sat 84% of the way up from that low.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Neogen Corporation is in stage 2. The phase helps read everything below.
Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row.
1Y
Nov 2026: $12.46, 19.1% above its 200-day average. The price has been rising for 28 weeks.
- Price $12.46
- 50-day avg $12.25
- 200-day avg $10.46
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 31 Oct 2025 | $6.17 | $5.80 | $6.77 |
| 7 Nov 2025 | $6.40 | $5.85 | $6.63 |
| 14 Nov 2025 | $6.39 | $5.92 | $6.50 |
| 21 Nov 2025 | $5.72 | $5.93 | $6.37 |
| 28 Nov 2025 | $5.98 | $5.98 | $6.29 |
| 5 Dec 2025 | $5.98 | $6.01 | $6.18 |
| 12 Dec 2025 | $6.86 | $6.11 | $6.09 |
| 19 Dec 2025 | $7.20 | $6.22 | $6.03 |
| 26 Dec 2025 | $7.13 | $6.32 | $5.97 |
| 2 Jan 2026 | $7.00 | $6.41 | $5.93 |
| 9 Jan 2026 | $9.62 | $6.62 | $5.92 |
| 16 Jan 2026 | $9.25 | $6.94 | $5.93 |
| 23 Jan 2026 | $9.80 | $7.22 | $5.97 |
| 30 Jan 2026 | $10.22 | $7.60 | $6.08 |
| 6 Feb 2026 | $10.80 | $8.08 | $6.22 |
| 13 Feb 2026 | $10.94 | $8.56 | $6.37 |
| 20 Feb 2026 | $11.33 | $8.97 | $6.48 |
| 27 Feb 2026 | $11.23 | $9.41 | $6.61 |
| 6 Mar 2026 | $9.70 | $9.76 | $6.71 |
| 13 Mar 2026 | $9.09 | $10.00 | $6.80 |
| 20 Mar 2026 | $8.36 | $10.16 | $6.87 |
| 27 Mar 2026 | $8.70 | $10.11 | $6.96 |
| 2 Apr 2026 | $9.41 | $10.10 | $7.04 |
| 10 Apr 2026 | $9.42 | $10.08 | $7.16 |
| 17 Apr 2026 | $9.51 | $9.98 | $7.27 |
| 24 Apr 2026 | $9.54 | $9.86 | $7.38 |
| 1 May 2026 | $9.53 | $9.70 | $7.48 |
| 8 May 2026 | $9.05 | $9.49 | $7.59 |
| 15 May 2026 | $8.19 | $9.25 | $7.67 |
| 22 May 2026 | $8.90 | $9.15 | $7.77 |
| 29 May 2026 | $8.97 | $9.16 | $7.86 |
| 5 Jun 2026 | $8.90 | $9.17 | $7.94 |
| 12 Jun 2026 | $9.10 | $9.17 | $8.03 |
| 18 Jun 2026 | $9.31 | $9.13 | $8.10 |
| 26 Jun 2026 | $9.58 | $9.09 | $8.19 |
| 2 Jul 2026 | $9.34 | $9.07 | $8.26 |
| 10 Jul 2026 | $9.62 | $9.08 | $8.36 |
| 17 Jul 2026 | $10.27 | $9.15 | $8.47 |
| 24 Jul 2026 | $9.40 | $9.23 | $8.57 |
| 31 Jul 2026 | $12.04 | $9.42 | $8.67 |
| 7 Aug 2026 | $11.47 | $9.68 | $8.82 |
| 14 Aug 2026 | $11.65 | $9.94 | $8.95 |
| 21 Aug 2026 | $11.95 | $10.22 | $9.09 |
| 28 Aug 2026 | $11.66 | $10.47 | $9.23 |
| 4 Sep 2026 | $11.83 | $10.72 | $9.36 |
| 11 Sep 2026 | $11.78 | $10.93 | $9.49 |
| 18 Sep 2026 | $13.00 | $11.23 | $9.65 |
| 25 Sep 2026 | $13.76 | $11.62 | $9.84 |
| 2 Oct 2026 | $12.15 | $11.90 | $9.99 |
| 9 Oct 2026 | $11.85 | $12.13 | $10.11 |
| 16 Oct 2026 | $11.81 | $12.16 | $10.23 |
| 23 Oct 2026 | $12.19 | $12.19 | $10.35 |
| 30 Oct 2026 | $11.82 | $12.23 | $10.42 |
| 4 Nov 2026 | $12.46 | $12.25 | $10.46 |
3Y
Nov 2026: $12.46, 19.1% above its 200-day average. The price has been rising for 28 weeks.
- Price $12.46
- 50-day avg $12.25
- 200-day avg $10.46
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 3 Nov 2023 | $15.82 | $18.22 | $19.22 |
| 10 Nov 2023 | $15.10 | $17.47 | $19.11 |
| 17 Nov 2023 | $16.15 | $16.91 | $18.99 |
| 24 Nov 2023 | $16.86 | $16.58 | $18.91 |
| 1 Dec 2023 | $17.44 | $16.26 | $18.84 |
| 8 Dec 2023 | $18.18 | $16.18 | $18.79 |
| 15 Dec 2023 | $19.42 | $16.27 | $18.80 |
| 22 Dec 2023 | $20.63 | $16.70 | $18.84 |
| 29 Dec 2023 | $20.11 | $17.10 | $18.90 |
| 5 Jan 2024 | $19.45 | $17.47 | $18.92 |
| 12 Jan 2024 | $18.18 | $17.82 | $18.93 |
| 19 Jan 2024 | $17.00 | $17.96 | $18.91 |
| 26 Jan 2024 | $16.14 | $18.09 | $18.89 |
| 2 Feb 2024 | $15.63 | $18.05 | $18.87 |
| 9 Feb 2024 | $16.55 | $17.97 | $18.84 |
| 16 Feb 2024 | $17.64 | $17.95 | $18.84 |
| 23 Feb 2024 | $16.96 | $17.88 | $18.84 |
| 1 Mar 2024 | $17.19 | $17.69 | $18.85 |
| 8 Mar 2024 | $16.37 | $17.33 | $18.85 |
| 15 Mar 2024 | $15.18 | $16.87 | $18.82 |
| 22 Mar 2024 | $15.21 | $16.48 | $18.74 |
| 28 Mar 2024 | $15.78 | $16.29 | $18.67 |
| 5 Apr 2024 | $14.35 | $16.05 | $18.52 |
| 12 Apr 2024 | $12.38 | $15.76 | $18.31 |
| 19 Apr 2024 | $11.61 | $15.41 | $18.07 |
| 26 Apr 2024 | $12.14 | $14.94 | $17.83 |
| 3 May 2024 | $12.02 | $14.44 | $17.57 |
| 10 May 2024 | $12.33 | $13.96 | $17.32 |
| 17 May 2024 | $13.54 | $13.59 | $17.08 |
| 24 May 2024 | $13.26 | $13.34 | $16.85 |
| 31 May 2024 | $13.15 | $13.18 | $16.66 |
| 7 Jun 2024 | $16.11 | $13.22 | $16.48 |
| 14 Jun 2024 | $17.01 | $13.42 | $16.33 |
| 21 Jun 2024 | $16.57 | $13.67 | $16.20 |
| 28 Jun 2024 | $15.63 | $14.04 | $16.10 |
| 5 Jul 2024 | $15.23 | $14.30 | $15.98 |
| 12 Jul 2024 | $16.45 | $14.63 | $15.88 |
| 19 Jul 2024 | $16.33 | $15.10 | $15.85 |
| 26 Jul 2024 | $17.33 | $15.54 | $15.84 |
| 2 Aug 2024 | $16.38 | $15.90 | $15.88 |
| 9 Aug 2024 | $16.80 | $16.23 | $15.92 |
| 16 Aug 2024 | $16.15 | $16.43 | $15.95 |
| 23 Aug 2024 | $16.78 | $16.42 | $15.97 |
| 30 Aug 2024 | $17.25 | $16.45 | $16.02 |
| 6 Sep 2024 | $15.42 | $16.42 | $16.02 |
| 13 Sep 2024 | $16.13 | $16.43 | $15.99 |
| 20 Sep 2024 | $17.46 | $16.61 | $15.99 |
| 27 Sep 2024 | $16.61 | $16.59 | $15.96 |
| 4 Oct 2024 | $15.07 | $16.48 | $15.87 |
| 11 Oct 2024 | $14.43 | $16.21 | $15.73 |
| 18 Oct 2024 | $14.50 | $16.00 | $15.58 |
| 25 Oct 2024 | $13.81 | $15.73 | $15.45 |
| 1 Nov 2024 | $14.44 | $15.54 | $15.37 |
| 8 Nov 2024 | $16.23 | $15.38 | $15.34 |
| 15 Nov 2024 | $14.60 | $15.29 | $15.32 |
| 22 Nov 2024 | $14.98 | $15.23 | $15.30 |
| 29 Nov 2024 | $14.18 | $15.03 | $15.26 |
| 6 Dec 2024 | $12.82 | $14.64 | $15.15 |
| 13 Dec 2024 | $12.15 | $14.31 | $15.04 |
| 20 Dec 2024 | $12.04 | $14.04 | $14.92 |
| 27 Dec 2024 | $12.43 | $13.87 | $14.84 |
| 3 Jan 2025 | $12.25 | $13.70 | $14.78 |
| 10 Jan 2025 | $12.36 | $13.62 | $14.73 |
| 17 Jan 2025 | $11.56 | $13.37 | $14.65 |
| 24 Jan 2025 | $11.47 | $13.05 | $14.60 |
| 31 Jan 2025 | $11.46 | $12.68 | $14.57 |
| 7 Feb 2025 | $10.37 | $12.26 | $14.54 |
| 14 Feb 2025 | $9.83 | $11.83 | $14.48 |
| 21 Feb 2025 | $10.04 | $11.61 | $14.44 |
| 28 Feb 2025 | $10.05 | $11.36 | $14.39 |
| 7 Mar 2025 | $10.40 | $11.14 | $14.30 |
| 14 Mar 2025 | $9.05 | $10.87 | $14.21 |
| 21 Mar 2025 | $8.85 | $10.54 | $14.10 |
| 28 Mar 2025 | $8.64 | $10.18 | $13.92 |
| 4 Apr 2025 | $7.80 | $9.84 | $13.70 |
| 11 Apr 2025 | $5.58 | $9.30 | $13.45 |
| 17 Apr 2025 | $4.39 | $8.81 | $13.23 |
| 25 Apr 2025 | $5.16 | $8.28 | $12.98 |
| 2 May 2025 | $5.75 | $7.79 | $12.69 |
| 9 May 2025 | $5.97 | $7.35 | $12.42 |
| 16 May 2025 | $6.61 | $7.03 | $12.15 |
| 23 May 2025 | $6.06 | $6.67 | $11.89 |
| 30 May 2025 | $5.86 | $6.42 | $11.68 |
| 6 Jun 2025 | $5.21 | $6.08 | $11.40 |
| 13 Jun 2025 | $5.53 | $5.78 | $11.13 |
| 20 Jun 2025 | $4.94 | $5.58 | $10.89 |
| 27 Jun 2025 | $4.73 | $5.53 | $10.62 |
| 3 Jul 2025 | $5.33 | $5.57 | $10.41 |
| 11 Jul 2025 | $5.39 | $5.60 | $10.12 |
| 18 Jul 2025 | $4.74 | $5.55 | $9.82 |
| 25 Jul 2025 | $5.22 | $5.44 | $9.55 |
| 1 Aug 2025 | $4.66 | $5.28 | $9.31 |
| 8 Aug 2025 | $5.08 | $5.15 | $9.07 |
| 15 Aug 2025 | $5.43 | $5.11 | $8.86 |
| 22 Aug 2025 | $5.64 | $5.13 | $8.64 |
| 29 Aug 2025 | $5.75 | $5.16 | $8.40 |
| 5 Sep 2025 | $5.75 | $5.22 | $8.21 |
| 12 Sep 2025 | $5.50 | $5.29 | $7.97 |
| 19 Sep 2025 | $5.61 | $5.31 | $7.75 |
| 26 Sep 2025 | $5.67 | $5.36 | $7.56 |
| 3 Oct 2025 | $6.06 | $5.44 | $7.39 |
| 10 Oct 2025 | $6.04 | $5.55 | $7.24 |
| 17 Oct 2025 | $5.88 | $5.66 | $7.08 |
| 24 Oct 2025 | $6.19 | $5.74 | $6.92 |
| 31 Oct 2025 | $6.17 | $5.80 | $6.77 |
| 7 Nov 2025 | $6.40 | $5.85 | $6.63 |
| 14 Nov 2025 | $6.39 | $5.92 | $6.50 |
| 21 Nov 2025 | $5.72 | $5.93 | $6.37 |
| 28 Nov 2025 | $5.98 | $5.98 | $6.29 |
| 5 Dec 2025 | $5.98 | $6.01 | $6.18 |
| 12 Dec 2025 | $6.86 | $6.11 | $6.09 |
| 19 Dec 2025 | $7.20 | $6.22 | $6.03 |
| 26 Dec 2025 | $7.13 | $6.32 | $5.97 |
| 2 Jan 2026 | $7.00 | $6.41 | $5.93 |
| 9 Jan 2026 | $9.62 | $6.62 | $5.92 |
| 16 Jan 2026 | $9.25 | $6.94 | $5.93 |
| 23 Jan 2026 | $9.80 | $7.22 | $5.97 |
| 30 Jan 2026 | $10.22 | $7.60 | $6.08 |
| 6 Feb 2026 | $10.80 | $8.08 | $6.22 |
| 13 Feb 2026 | $10.94 | $8.56 | $6.37 |
| 20 Feb 2026 | $11.33 | $8.97 | $6.48 |
| 27 Feb 2026 | $11.23 | $9.41 | $6.61 |
| 6 Mar 2026 | $9.70 | $9.76 | $6.71 |
| 13 Mar 2026 | $9.09 | $10.00 | $6.80 |
| 20 Mar 2026 | $8.36 | $10.16 | $6.87 |
| 27 Mar 2026 | $8.70 | $10.11 | $6.96 |
| 2 Apr 2026 | $9.41 | $10.10 | $7.04 |
| 10 Apr 2026 | $9.42 | $10.08 | $7.16 |
| 17 Apr 2026 | $9.51 | $9.98 | $7.27 |
| 24 Apr 2026 | $9.54 | $9.86 | $7.38 |
| 1 May 2026 | $9.53 | $9.70 | $7.48 |
| 8 May 2026 | $9.05 | $9.49 | $7.59 |
| 15 May 2026 | $8.19 | $9.25 | $7.67 |
| 22 May 2026 | $8.90 | $9.15 | $7.77 |
| 29 May 2026 | $8.97 | $9.16 | $7.86 |
| 5 Jun 2026 | $8.90 | $9.17 | $7.94 |
| 12 Jun 2026 | $9.10 | $9.17 | $8.03 |
| 18 Jun 2026 | $9.31 | $9.13 | $8.10 |
| 26 Jun 2026 | $9.58 | $9.09 | $8.19 |
| 2 Jul 2026 | $9.34 | $9.07 | $8.26 |
| 10 Jul 2026 | $9.62 | $9.08 | $8.36 |
| 17 Jul 2026 | $10.27 | $9.15 | $8.47 |
| 24 Jul 2026 | $9.40 | $9.23 | $8.57 |
| 31 Jul 2026 | $12.04 | $9.42 | $8.67 |
| 7 Aug 2026 | $11.47 | $9.68 | $8.82 |
| 14 Aug 2026 | $11.65 | $9.94 | $8.95 |
| 21 Aug 2026 | $11.95 | $10.22 | $9.09 |
| 28 Aug 2026 | $11.66 | $10.47 | $9.23 |
| 4 Sep 2026 | $11.83 | $10.72 | $9.36 |
| 11 Sep 2026 | $11.78 | $10.93 | $9.49 |
| 18 Sep 2026 | $13.00 | $11.23 | $9.65 |
| 25 Sep 2026 | $13.76 | $11.62 | $9.84 |
| 2 Oct 2026 | $12.15 | $11.90 | $9.99 |
| 9 Oct 2026 | $11.85 | $12.13 | $10.11 |
| 16 Oct 2026 | $11.81 | $12.16 | $10.23 |
| 23 Oct 2026 | $12.19 | $12.19 | $10.35 |
| 30 Oct 2026 | $11.82 | $12.23 | $10.42 |
| 4 Nov 2026 | $12.46 | $12.25 | $10.46 |
5Y
Nov 2026: $12.46, 19.1% above its 200-day average. The price has been rising for 28 weeks.
- Price $12.46
- 50-day avg $12.25
- 200-day avg $10.46
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 29 Oct 2021 | $42.31 | $42.45 | $43.78 |
| 12 Nov 2021 | $44.28 | $42.57 | $43.89 |
| 26 Nov 2021 | $41.19 | $42.75 | $43.95 |
| 10 Dec 2021 | $40.20 | $42.30 | $43.86 |
| 23 Dec 2021 | $44.41 | $42.59 | $44.00 |
| 7 Jan 2022 | $40.03 | $43.20 | $44.11 |
| 21 Jan 2022 | $35.03 | $42.18 | $43.82 |
| 4 Feb 2022 | $35.47 | $40.46 | $43.25 |
| 18 Feb 2022 | $35.22 | $39.49 | $42.66 |
| 4 Mar 2022 | $35.77 | $38.21 | $42.19 |
| 18 Mar 2022 | $35.35 | $36.11 | $41.63 |
| 1 Apr 2022 | $31.52 | $34.81 | $40.97 |
| 14 Apr 2022 | $30.06 | $33.99 | $40.31 |
| 29 Apr 2022 | $26.40 | $32.42 | $39.45 |
| 13 May 2022 | $26.48 | $30.71 | $38.60 |
| 27 May 2022 | $26.68 | $29.04 | $37.76 |
| 10 Jun 2022 | $24.02 | $27.76 | $36.99 |
| 24 Jun 2022 | $24.61 | $26.33 | $36.06 |
| 8 Jul 2022 | $23.39 | $25.42 | $35.27 |
| 22 Jul 2022 | $22.01 | $24.45 | $34.22 |
| 5 Aug 2022 | $21.42 | $23.66 | $33.27 |
| 19 Aug 2022 | $21.01 | $22.75 | $32.26 |
| 2 Sep 2022 | $18.03 | $22.17 | $31.05 |
| 16 Sep 2022 | $16.11 | $20.90 | $29.90 |
| 30 Sep 2022 | $13.97 | $19.37 | $28.61 |
| 14 Oct 2022 | $11.33 | $17.45 | $27.00 |
| 28 Oct 2022 | $13.13 | $15.45 | $25.47 |
| 11 Nov 2022 | $16.28 | $14.11 | $24.35 |
| 25 Nov 2022 | $16.27 | $13.86 | $23.45 |
| 9 Dec 2022 | $15.10 | $14.01 | $22.46 |
| 23 Dec 2022 | $14.87 | $14.42 | $21.44 |
| 6 Jan 2023 | $16.37 | $15.08 | $20.67 |
| 20 Jan 2023 | $19.62 | $15.99 | $20.07 |
| 3 Feb 2023 | $20.29 | $16.94 | $19.55 |
| 17 Feb 2023 | $20.35 | $17.77 | $19.18 |
| 3 Mar 2023 | $19.08 | $18.41 | $18.81 |
| 17 Mar 2023 | $18.48 | $19.03 | $18.40 |
| 31 Mar 2023 | $18.52 | $19.15 | $18.06 |
| 14 Apr 2023 | $16.10 | $18.62 | $17.77 |
| 28 Apr 2023 | $17.22 | $17.95 | $17.44 |
| 12 May 2023 | $16.56 | $17.56 | $17.18 |
| 26 May 2023 | $17.11 | $17.26 | $16.91 |
| 9 Jun 2023 | $18.57 | $17.27 | $16.78 |
| 23 Jun 2023 | $21.69 | $17.81 | $16.80 |
| 7 Jul 2023 | $21.30 | $18.68 | $17.00 |
| 21 Jul 2023 | $22.56 | $19.73 | $17.40 |
| 4 Aug 2023 | $22.83 | $20.91 | $17.90 |
| 18 Aug 2023 | $22.50 | $21.88 | $18.44 |
| 1 Sep 2023 | $23.33 | $22.45 | $18.87 |
| 15 Sep 2023 | $20.76 | $22.31 | $19.09 |
| 29 Sep 2023 | $18.54 | $21.70 | $19.27 |
| 13 Oct 2023 | $15.47 | $20.50 | $19.34 |
| 27 Oct 2023 | $15.32 | $18.97 | $19.30 |
| 10 Nov 2023 | $15.10 | $17.47 | $19.11 |
| 24 Nov 2023 | $16.86 | $16.58 | $18.91 |
| 8 Dec 2023 | $18.18 | $16.18 | $18.79 |
| 22 Dec 2023 | $20.63 | $16.70 | $18.84 |
| 5 Jan 2024 | $19.45 | $17.47 | $18.92 |
| 19 Jan 2024 | $17.00 | $17.96 | $18.91 |
| 2 Feb 2024 | $15.63 | $18.05 | $18.87 |
| 16 Feb 2024 | $17.64 | $17.95 | $18.84 |
| 1 Mar 2024 | $17.19 | $17.69 | $18.85 |
| 15 Mar 2024 | $15.18 | $16.87 | $18.82 |
| 28 Mar 2024 | $15.78 | $16.29 | $18.67 |
| 12 Apr 2024 | $12.38 | $15.76 | $18.31 |
| 26 Apr 2024 | $12.14 | $14.94 | $17.83 |
| 10 May 2024 | $12.33 | $13.96 | $17.32 |
| 24 May 2024 | $13.26 | $13.34 | $16.85 |
| 7 Jun 2024 | $16.11 | $13.22 | $16.48 |
| 21 Jun 2024 | $16.57 | $13.67 | $16.20 |
| 5 Jul 2024 | $15.23 | $14.30 | $15.98 |
| 19 Jul 2024 | $16.33 | $15.10 | $15.85 |
| 2 Aug 2024 | $16.38 | $15.90 | $15.88 |
| 16 Aug 2024 | $16.15 | $16.43 | $15.95 |
| 30 Aug 2024 | $17.25 | $16.45 | $16.02 |
| 13 Sep 2024 | $16.13 | $16.43 | $15.99 |
| 27 Sep 2024 | $16.61 | $16.59 | $15.96 |
| 11 Oct 2024 | $14.43 | $16.21 | $15.73 |
| 25 Oct 2024 | $13.81 | $15.73 | $15.45 |
| 8 Nov 2024 | $16.23 | $15.38 | $15.34 |
| 22 Nov 2024 | $14.98 | $15.23 | $15.30 |
| 6 Dec 2024 | $12.82 | $14.64 | $15.15 |
| 20 Dec 2024 | $12.04 | $14.04 | $14.92 |
| 3 Jan 2025 | $12.25 | $13.70 | $14.78 |
| 17 Jan 2025 | $11.56 | $13.37 | $14.65 |
| 31 Jan 2025 | $11.46 | $12.68 | $14.57 |
| 14 Feb 2025 | $9.83 | $11.83 | $14.48 |
| 28 Feb 2025 | $10.05 | $11.36 | $14.39 |
| 14 Mar 2025 | $9.05 | $10.87 | $14.21 |
| 28 Mar 2025 | $8.64 | $10.18 | $13.92 |
| 11 Apr 2025 | $5.58 | $9.30 | $13.45 |
| 25 Apr 2025 | $5.16 | $8.28 | $12.98 |
| 9 May 2025 | $5.97 | $7.35 | $12.42 |
| 23 May 2025 | $6.06 | $6.67 | $11.89 |
| 6 Jun 2025 | $5.21 | $6.08 | $11.40 |
| 20 Jun 2025 | $4.94 | $5.58 | $10.89 |
| 3 Jul 2025 | $5.33 | $5.57 | $10.41 |
| 18 Jul 2025 | $4.74 | $5.55 | $9.82 |
| 1 Aug 2025 | $4.66 | $5.28 | $9.31 |
| 15 Aug 2025 | $5.43 | $5.11 | $8.86 |
| 29 Aug 2025 | $5.75 | $5.16 | $8.40 |
| 12 Sep 2025 | $5.50 | $5.29 | $7.97 |
| 26 Sep 2025 | $5.67 | $5.36 | $7.56 |
| 10 Oct 2025 | $6.04 | $5.55 | $7.24 |
| 24 Oct 2025 | $6.19 | $5.74 | $6.92 |
| 7 Nov 2025 | $6.40 | $5.85 | $6.63 |
| 21 Nov 2025 | $5.72 | $5.93 | $6.37 |
| 5 Dec 2025 | $5.98 | $6.01 | $6.18 |
| 19 Dec 2025 | $7.20 | $6.22 | $6.03 |
| 2 Jan 2026 | $7.00 | $6.41 | $5.93 |
| 16 Jan 2026 | $9.25 | $6.94 | $5.93 |
| 30 Jan 2026 | $10.22 | $7.60 | $6.08 |
| 13 Feb 2026 | $10.94 | $8.56 | $6.37 |
| 27 Feb 2026 | $11.23 | $9.41 | $6.61 |
| 13 Mar 2026 | $9.09 | $10.00 | $6.80 |
| 27 Mar 2026 | $8.70 | $10.11 | $6.96 |
| 10 Apr 2026 | $9.42 | $10.08 | $7.16 |
| 24 Apr 2026 | $9.54 | $9.86 | $7.38 |
| 8 May 2026 | $9.05 | $9.49 | $7.59 |
| 22 May 2026 | $8.90 | $9.15 | $7.77 |
| 5 Jun 2026 | $8.90 | $9.17 | $7.94 |
| 18 Jun 2026 | $9.31 | $9.13 | $8.10 |
| 2 Jul 2026 | $9.34 | $9.07 | $8.26 |
| 17 Jul 2026 | $10.27 | $9.15 | $8.47 |
| 31 Jul 2026 | $12.04 | $9.42 | $8.67 |
| 14 Aug 2026 | $11.65 | $9.94 | $8.95 |
| 28 Aug 2026 | $11.66 | $10.47 | $9.23 |
| 11 Sep 2026 | $11.78 | $10.93 | $9.49 |
| 25 Sep 2026 | $13.76 | $11.62 | $9.84 |
| 9 Oct 2026 | $11.85 | $12.13 | $10.11 |
| 23 Oct 2026 | $12.19 | $12.19 | $10.35 |
| 4 Nov 2026 | $12.46 | $12.25 | $10.46 |
10Y
Nov 2026: $12.46, 19.1% above its 200-day average. The price has been rising for 28 weeks.
- Price $12.46
- 50-day avg $12.25
- 200-day avg $10.46
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 28 Oct 2016 | $19.54 | $21.07 | – |
| 18 Nov 2016 | $22.75 | $20.86 | – |
| 9 Dec 2016 | $25.46 | $21.52 | – |
| 30 Dec 2016 | $24.75 | $22.68 | – |
| 20 Jan 2017 | $23.76 | $23.98 | – |
| 10 Feb 2017 | $24.61 | $24.41 | – |
| 3 Mar 2017 | $24.51 | $24.52 | – |
| 24 Mar 2017 | $23.98 | $24.45 | – |
| 13 Apr 2017 | $22.37 | $24.23 | – |
| 5 May 2017 | $23.51 | $23.88 | $22.83 |
| 26 May 2017 | $23.62 | $23.52 | $23.01 |
| 16 Jun 2017 | $25.55 | $23.63 | $23.23 |
| 7 Jul 2017 | $25.63 | $24.36 | $23.49 |
| 28 Jul 2017 | $24.39 | $24.84 | $23.79 |
| 18 Aug 2017 | $24.45 | $25.20 | $24.18 |
| 8 Sep 2017 | $26.14 | $25.18 | $24.44 |
| 29 Sep 2017 | $29.05 | $25.78 | $24.70 |
| 20 Oct 2017 | $30.06 | $27.15 | $25.06 |
| 10 Nov 2017 | $30.76 | $28.76 | $25.50 |
| 1 Dec 2017 | $31.42 | $29.96 | $25.96 |
| 22 Dec 2017 | $30.94 | $30.40 | $26.41 |
| 12 Jan 2018 | $29.56 | $30.49 | $26.76 |
| 2 Feb 2018 | $29.55 | $30.26 | $27.21 |
| 23 Feb 2018 | $30.05 | $29.66 | $27.59 |
| 16 Mar 2018 | $32.16 | $29.74 | $28.15 |
| 6 Apr 2018 | $33.65 | $30.65 | $28.70 |
| 27 Apr 2018 | $34.18 | $32.29 | $29.35 |
| 18 May 2018 | $37.35 | $34.06 | $30.18 |
| 8 Jun 2018 | $38.94 | $35.69 | $31.08 |
| 29 Jun 2018 | $40.09 | $37.66 | $32.20 |
| 20 Jul 2018 | $41.05 | $39.47 | $33.13 |
| 10 Aug 2018 | $41.80 | $40.73 | $34.01 |
| 31 Aug 2018 | $46.72 | $41.85 | $35.00 |
| 21 Sep 2018 | $44.70 | $43.29 | $36.07 |
| 12 Oct 2018 | $32.46 | $41.47 | $36.40 |
| 2 Nov 2018 | $31.66 | $38.30 | $36.54 |
| 23 Nov 2018 | $30.66 | $34.24 | $36.68 |
| 14 Dec 2018 | $31.11 | $31.67 | $36.84 |
| 4 Jan 2019 | $28.05 | $30.49 | $36.63 |
| 25 Jan 2019 | $30.44 | $30.04 | $36.40 |
| 15 Feb 2019 | $31.50 | $29.84 | $36.12 |
| 8 Mar 2019 | $29.36 | $30.05 | $35.74 |
| 29 Mar 2019 | $28.70 | $30.55 | $35.15 |
| 18 Apr 2019 | $28.38 | $30.04 | $34.29 |
| 10 May 2019 | $30.98 | $29.69 | $33.45 |
| 31 May 2019 | $28.18 | $29.22 | $32.59 |
| 21 Jun 2019 | $31.07 | $29.52 | $31.56 |
| 12 Jul 2019 | $31.50 | $29.96 | $30.46 |
| 2 Aug 2019 | $35.15 | $31.04 | $30.43 |
| 23 Aug 2019 | $34.80 | $33.00 | $30.71 |
| 13 Sep 2019 | $39.29 | $34.53 | $31.06 |
| 4 Oct 2019 | $32.08 | $35.45 | $31.33 |
| 25 Oct 2019 | $32.43 | $34.60 | $31.64 |
| 15 Nov 2019 | $32.47 | $33.76 | $31.84 |
| 6 Dec 2019 | $33.81 | $32.65 | $31.99 |
| 27 Dec 2019 | $32.53 | $33.11 | $32.21 |
| 17 Jan 2020 | $35.64 | $33.25 | $32.46 |
| 7 Feb 2020 | $34.41 | $33.82 | $32.87 |
| 28 Feb 2020 | $30.38 | $34.15 | $33.19 |
| 20 Mar 2020 | $28.36 | $33.15 | $33.28 |
| 9 Apr 2020 | $31.75 | $32.32 | $33.34 |
| 1 May 2020 | $30.51 | $31.30 | $33.42 |
| 22 May 2020 | $33.41 | $31.49 | $33.29 |
| 12 Jun 2020 | $34.30 | $33.17 | $33.31 |
| 2 Jul 2020 | $38.97 | $34.55 | $33.32 |
| 24 Jul 2020 | $37.45 | $36.54 | $33.67 |
| 14 Aug 2020 | $38.32 | $37.89 | $34.15 |
| 4 Sep 2020 | $37.15 | $38.40 | $34.55 |
| 25 Sep 2020 | $37.70 | $38.11 | $34.84 |
| 16 Oct 2020 | $35.71 | $37.47 | $35.05 |
| 6 Nov 2020 | $35.52 | $36.55 | $35.15 |
| 27 Nov 2020 | $37.44 | $36.25 | $35.28 |
| 18 Dec 2020 | $40.40 | $36.85 | $35.70 |
| 8 Jan 2021 | $41.92 | $38.13 | $36.44 |
| 29 Jan 2021 | $40.44 | $39.93 | $37.16 |
| 19 Feb 2021 | $42.20 | $41.42 | $37.91 |
| 12 Mar 2021 | $42.40 | $41.68 | $38.50 |
| 1 Apr 2021 | $44.66 | $42.06 | $38.99 |
| 23 Apr 2021 | $48.30 | $43.38 | $39.67 |
| 14 May 2021 | $46.43 | $44.98 | $40.32 |
| 4 Jun 2021 | $45.24 | $46.15 | $40.80 |
| 25 Jun 2021 | $45.95 | $46.33 | $41.39 |
| 16 Jul 2021 | $44.43 | $45.71 | $41.93 |
| 6 Aug 2021 | $43.77 | $44.95 | $42.51 |
| 27 Aug 2021 | $43.75 | $44.19 | $43.08 |
| 17 Sep 2021 | $41.38 | $43.41 | $43.52 |
| 8 Oct 2021 | $41.42 | $42.95 | $43.75 |
| 29 Oct 2021 | $42.31 | $42.45 | $43.78 |
| 19 Nov 2021 | $44.00 | $42.63 | $43.95 |
| 10 Dec 2021 | $40.20 | $42.30 | $43.86 |
| 31 Dec 2021 | $45.41 | $43.08 | $44.09 |
| 21 Jan 2022 | $35.03 | $42.18 | $43.82 |
| 11 Feb 2022 | $36.16 | $39.96 | $42.95 |
| 4 Mar 2022 | $35.77 | $38.21 | $42.19 |
| 25 Mar 2022 | $31.24 | $35.41 | $41.33 |
| 14 Apr 2022 | $30.06 | $33.99 | $40.31 |
| 6 May 2022 | $27.80 | $31.66 | $39.04 |
| 27 May 2022 | $26.68 | $29.04 | $37.76 |
| 17 Jun 2022 | $22.84 | $26.93 | $36.47 |
| 8 Jul 2022 | $23.39 | $25.42 | $35.27 |
| 29 Jul 2022 | $23.13 | $24.10 | $33.75 |
| 19 Aug 2022 | $21.01 | $22.75 | $32.26 |
| 9 Sep 2022 | $18.46 | $21.65 | $30.53 |
| 30 Sep 2022 | $13.97 | $19.37 | $28.61 |
| 21 Oct 2022 | $11.03 | $16.40 | $26.16 |
| 11 Nov 2022 | $16.28 | $14.11 | $24.35 |
| 2 Dec 2022 | $16.43 | $13.91 | $22.95 |
| 23 Dec 2022 | $14.87 | $14.42 | $21.44 |
| 13 Jan 2023 | $17.86 | $15.54 | $20.31 |
| 3 Feb 2023 | $20.29 | $16.94 | $19.55 |
| 24 Feb 2023 | $18.61 | $18.07 | $19.00 |
| 17 Mar 2023 | $18.48 | $19.03 | $18.40 |
| 6 Apr 2023 | $17.11 | $18.97 | $17.95 |
| 28 Apr 2023 | $17.22 | $17.95 | $17.44 |
| 19 May 2023 | $16.43 | $17.39 | $17.03 |
| 9 Jun 2023 | $18.57 | $17.27 | $16.78 |
| 30 Jun 2023 | $21.75 | $18.33 | $16.90 |
| 21 Jul 2023 | $22.56 | $19.73 | $17.40 |
| 11 Aug 2023 | $22.50 | $21.45 | $18.18 |
| 1 Sep 2023 | $23.33 | $22.45 | $18.87 |
| 22 Sep 2023 | $19.06 | $22.10 | $19.18 |
| 13 Oct 2023 | $15.47 | $20.50 | $19.34 |
| 3 Nov 2023 | $15.82 | $18.22 | $19.22 |
| 24 Nov 2023 | $16.86 | $16.58 | $18.91 |
| 15 Dec 2023 | $19.42 | $16.27 | $18.80 |
| 5 Jan 2024 | $19.45 | $17.47 | $18.92 |
| 26 Jan 2024 | $16.14 | $18.09 | $18.89 |
| 16 Feb 2024 | $17.64 | $17.95 | $18.84 |
| 8 Mar 2024 | $16.37 | $17.33 | $18.85 |
| 28 Mar 2024 | $15.78 | $16.29 | $18.67 |
| 19 Apr 2024 | $11.61 | $15.41 | $18.07 |
| 10 May 2024 | $12.33 | $13.96 | $17.32 |
| 31 May 2024 | $13.15 | $13.18 | $16.66 |
| 21 Jun 2024 | $16.57 | $13.67 | $16.20 |
| 12 Jul 2024 | $16.45 | $14.63 | $15.88 |
| 2 Aug 2024 | $16.38 | $15.90 | $15.88 |
| 23 Aug 2024 | $16.78 | $16.42 | $15.97 |
| 13 Sep 2024 | $16.13 | $16.43 | $15.99 |
| 4 Oct 2024 | $15.07 | $16.48 | $15.87 |
| 25 Oct 2024 | $13.81 | $15.73 | $15.45 |
| 15 Nov 2024 | $14.60 | $15.29 | $15.32 |
| 6 Dec 2024 | $12.82 | $14.64 | $15.15 |
| 27 Dec 2024 | $12.43 | $13.87 | $14.84 |
| 17 Jan 2025 | $11.56 | $13.37 | $14.65 |
| 7 Feb 2025 | $10.37 | $12.26 | $14.54 |
| 28 Feb 2025 | $10.05 | $11.36 | $14.39 |
| 21 Mar 2025 | $8.85 | $10.54 | $14.10 |
| 11 Apr 2025 | $5.58 | $9.30 | $13.45 |
| 2 May 2025 | $5.75 | $7.79 | $12.69 |
| 23 May 2025 | $6.06 | $6.67 | $11.89 |
| 13 Jun 2025 | $5.53 | $5.78 | $11.13 |
| 3 Jul 2025 | $5.33 | $5.57 | $10.41 |
| 25 Jul 2025 | $5.22 | $5.44 | $9.55 |
| 15 Aug 2025 | $5.43 | $5.11 | $8.86 |
| 5 Sep 2025 | $5.75 | $5.22 | $8.21 |
| 26 Sep 2025 | $5.67 | $5.36 | $7.56 |
| 17 Oct 2025 | $5.88 | $5.66 | $7.08 |
| 7 Nov 2025 | $6.40 | $5.85 | $6.63 |
| 28 Nov 2025 | $5.98 | $5.98 | $6.29 |
| 19 Dec 2025 | $7.20 | $6.22 | $6.03 |
| 9 Jan 2026 | $9.62 | $6.62 | $5.92 |
| 30 Jan 2026 | $10.22 | $7.60 | $6.08 |
| 20 Feb 2026 | $11.33 | $8.97 | $6.48 |
| 13 Mar 2026 | $9.09 | $10.00 | $6.80 |
| 2 Apr 2026 | $9.41 | $10.10 | $7.04 |
| 24 Apr 2026 | $9.54 | $9.86 | $7.38 |
| 15 May 2026 | $8.19 | $9.25 | $7.67 |
| 5 Jun 2026 | $8.90 | $9.17 | $7.94 |
| 26 Jun 2026 | $9.58 | $9.09 | $8.19 |
| 17 Jul 2026 | $10.27 | $9.15 | $8.47 |
| 7 Aug 2026 | $11.47 | $9.68 | $8.82 |
| 28 Aug 2026 | $11.66 | $10.47 | $9.23 |
| 18 Sep 2026 | $13.00 | $11.23 | $9.65 |
| 9 Oct 2026 | $11.85 | $12.13 | $10.11 |
| 30 Oct 2026 | $11.82 | $12.23 | $10.42 |
| 4 Nov 2026 | $12.46 | $12.25 | $10.46 |
Price stage: Falling from Oct 2025 to Dec 2025; Sideways from Dec 2025 to Apr 2026; Rising from May 2026 to Nov 2026.
Price stage: Sideways from Nov 2023 to Dec 2023; Rising from Dec 2023 to Jan 2024; Sideways from Jan 2024 to Mar 2024; Falling from Mar 2024 to Jul 2024; Sideways from Jul 2024 to Sep 2024; Falling from Oct 2024 to Dec 2025; Sideways from Dec 2025 to Apr 2026; Rising from May 2026 to Nov 2026.
Price stage: Sideways from Oct 2021 to Mar 2022; Falling from Mar 2022 to Jan 2023; Sideways from Feb 2023 to Mar 2023; Falling from Apr 2023 to May 2023; Sideways from May 2023 to Sep 2023; Sideways from Sep 2023 to Mar 2024; Falling from Mar 2024 to Jul 2024; Sideways from Jul 2024 to Nov 2024; Falling from Nov 2024 to Dec 2025; Sideways from Dec 2025 to Apr 2026; Rising from May 2026 to Nov 2026.
Price stage: Rising from Dec 2017 to Sep 2018; Sideways from Oct 2018 to Mar 2019; Falling from Apr 2019 to Jun 2019; Sideways from Jul 2019 to Feb 2020; Sideways from Feb 2020 to May 2020; Rising from May 2020 to Aug 2021; Sideways from Sep 2021 to Mar 2022; Falling from Mar 2022 to May 2023; Sideways from Jun 2023 to Sep 2023; Sideways from Sep 2023 to Mar 2024; Falling from Mar 2024 to May 2024; Sideways from Jun 2024 to Sep 2024; Falling from Oct 2024 to Nov 2025; Sideways from Dec 2025 to Apr 2026; Rising from May 2026 to Nov 2026.
Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Ahead in 215 of 527 weeks
| Week | 13-week return vs S&P 500 |
|---|---|
| 8 Jul 2016 | no S&P 500 reading |
| 15 Jul 2016 | no S&P 500 reading |
| 22 Jul 2016 | no S&P 500 reading |
| 29 Jul 2016 | no S&P 500 reading |
| 5 Aug 2016 | no S&P 500 reading |
| 12 Aug 2016 | no S&P 500 reading |
| 19 Aug 2016 | no S&P 500 reading |
| 26 Aug 2016 | no S&P 500 reading |
| 2 Sep 2016 | no S&P 500 reading |
| 9 Sep 2016 | no S&P 500 reading |
| 16 Sep 2016 | no S&P 500 reading |
| 23 Sep 2016 | no S&P 500 reading |
| 30 Sep 2016 | no S&P 500 reading |
| 7 Oct 2016 | −7.0% |
| 14 Oct 2016 | −4.8% |
| 21 Oct 2016 | −5.1% |
| 28 Oct 2016 | −3.4% |
| 4 Nov 2016 | +0.1% |
| 11 Nov 2016 | +8.5% |
| 18 Nov 2016 | +6.5% |
| 25 Nov 2016 | +5.3% |
| 2 Dec 2016 | +0.5% |
| 9 Dec 2016 | +14.2% |
| 16 Dec 2016 | +3.5% |
| 23 Dec 2016 | +9.4% |
| 30 Dec 2016 | +14.6% |
| 6 Jan 2017 | +12.8% |
| 13 Jan 2017 | +19.6% |
| 20 Jan 2017 | +15.6% |
| 27 Jan 2017 | +17.1% |
| 3 Feb 2017 | +14.0% |
| 10 Feb 2017 | −0.1% |
| 17 Feb 2017 | +1.1% |
| 24 Feb 2017 | −2.7% |
| 3 Mar 2017 | −2.4% |
| 10 Mar 2017 | −9.5% |
| 17 Mar 2017 | +2.7% |
| 24 Mar 2017 | −7.5% |
| 31 Mar 2017 | −6.1% |
| 7 Apr 2017 | −8.7% |
| 13 Apr 2017 | −12.4% |
| 21 Apr 2017 | −6.5% |
| 28 Apr 2017 | −8.2% |
| 5 May 2017 | −8.7% |
| 12 May 2017 | −10.6% |
| 19 May 2017 | −8.7% |
| 26 May 2017 | −6.2% |
| 2 Jun 2017 | −1.7% |
| 9 Jun 2017 | +2.0% |
| 16 Jun 2017 | −3.0% |
| 23 Jun 2017 | +2.7% |
| 30 Jun 2017 | +2.9% |
| 7 Jul 2017 | +7.4% |
| 14 Jul 2017 | +8.8% |
| 21 Jul 2017 | +4.1% |
| 28 Jul 2017 | +0.7% |
| 4 Aug 2017 | +3.3% |
| 11 Aug 2017 | +8.0% |
| 18 Aug 2017 | +4.9% |
| 25 Aug 2017 | +4.7% |
| 1 Sep 2017 | +4.2% |
| 8 Sep 2017 | +1.8% |
| 15 Sep 2017 | +4.5% |
| 22 Sep 2017 | +4.3% |
| 29 Sep 2017 | +8.2% |
| 6 Oct 2017 | +10.2% |
| 13 Oct 2017 | +8.9% |
| 20 Oct 2017 | +15.2% |
| 27 Oct 2017 | +19.5% |
| 3 Nov 2017 | +17.9% |
| 10 Nov 2017 | +16.8% |
| 17 Nov 2017 | +17.0% |
| 24 Nov 2017 | +18.5% |
| 1 Dec 2017 | +13.7% |
| 8 Dec 2017 | +8.7% |
| 15 Dec 2017 | +4.5% |
| 22 Dec 2017 | +5.9% |
| 29 Dec 2017 | −0.1% |
| 5 Jan 2018 | −6.5% |
| 12 Jan 2018 | −6.5% |
| 19 Jan 2018 | −11.1% |
| 26 Jan 2018 | −11.5% |
| 2 Feb 2018 | −10.2% |
| 9 Feb 2018 | −10.2% |
| 16 Feb 2018 | −6.7% |
| 23 Feb 2018 | −9.3% |
| 2 Mar 2018 | −6.5% |
| 9 Mar 2018 | −3.6% |
| 16 Mar 2018 | +2.5% |
| 23 Mar 2018 | +4.0% |
| 29 Mar 2018 | +10.0% |
| 6 Apr 2018 | +17.9% |
| 13 Apr 2018 | +20.7% |
| 20 Apr 2018 | +23.6% |
| 27 Apr 2018 | +20.5% |
| 4 May 2018 | +24.1% |
| 11 May 2018 | +25.8% |
| 18 May 2018 | +25.6% |
| 25 May 2018 | +23.0% |
| 1 Jun 2018 | +24.6% |
| 8 Jun 2018 | +26.4% |
| 15 Jun 2018 | +26.2% |
| 22 Jun 2018 | +28.0% |
| 29 Jun 2018 | +16.6% |
| 6 Jul 2018 | +18.4% |
| 13 Jul 2018 | +14.0% |
| 20 Jul 2018 | +12.6% |
| 27 Jul 2018 | +12.9% |
| 3 Aug 2018 | +7.7% |
| 10 Aug 2018 | +10.8% |
| 17 Aug 2018 | +7.6% |
| 24 Aug 2018 | +15.4% |
| 31 Aug 2018 | +17.4% |
| 7 Sep 2018 | +15.8% |
| 14 Sep 2018 | +12.9% |
| 21 Sep 2018 | +0.7% |
| 28 Sep 2018 | −17.9% |
| 5 Oct 2018 | −24.6% |
| 12 Oct 2018 | −19.5% |
| 19 Oct 2018 | −21.9% |
| 26 Oct 2018 | −18.2% |
| 2 Nov 2018 | −18.2% |
| 9 Nov 2018 | −21.7% |
| 16 Nov 2018 | −20.7% |
| 23 Nov 2018 | −22.5% |
| 30 Nov 2018 | −25.5% |
| 7 Dec 2018 | −25.4% |
| 14 Dec 2018 | −25.1% |
| 21 Dec 2018 | −21.7% |
| 28 Dec 2018 | −7.1% |
| 4 Jan 2019 | −3.8% |
| 11 Jan 2019 | −2.7% |
| 18 Jan 2019 | −0.6% |
| 25 Jan 2019 | −1.4% |
| 1 Feb 2019 | −3.1% |
| 8 Feb 2019 | −1.9% |
| 15 Feb 2019 | −1.9% |
| 22 Feb 2019 | −3.4% |
| 1 Mar 2019 | −3.8% |
| 8 Mar 2019 | −8.7% |
| 15 Mar 2019 | −8.0% |
| 22 Mar 2019 | −6.1% |
| 29 Mar 2019 | −11.3% |
| 5 Apr 2019 | −11.8% |
| 12 Apr 2019 | −15.1% |
| 18 Apr 2019 | −15.0% |
| 26 Apr 2019 | −13.1% |
| 3 May 2019 | −7.9% |
| 10 May 2019 | −4.9% |
| 17 May 2019 | −9.5% |
| 24 May 2019 | −10.6% |
| 31 May 2019 | −9.5% |
| 7 Jun 2019 | −8.2% |
| 14 Jun 2019 | −3.2% |
| 21 Jun 2019 | −1.2% |
| 28 Jun 2019 | +4.5% |
| 5 Jul 2019 | +3.1% |
| 12 Jul 2019 | +6.2% |
| 19 Jul 2019 | +10.2% |
| 26 Jul 2019 | +15.5% |
| 2 Aug 2019 | +14.7% |
| 9 Aug 2019 | +12.7% |
| 16 Aug 2019 | +19.4% |
| 23 Aug 2019 | +21.2% |
| 30 Aug 2019 | +18.9% |
| 6 Sep 2019 | +23.7% |
| 13 Sep 2019 | +22.7% |
| 20 Sep 2019 | +19.3% |
| 27 Sep 2019 | +4.2% |
| 4 Oct 2019 | +6.1% |
| 11 Oct 2019 | +2.9% |
| 18 Oct 2019 | +0.9% |
| 25 Oct 2019 | −7.4% |
| 1 Nov 2019 | −11.8% |
| 8 Nov 2019 | −14.9% |
| 15 Nov 2019 | −16.4% |
| 22 Nov 2019 | −15.2% |
| 29 Nov 2019 | −13.1% |
| 6 Dec 2019 | −12.0% |
| 13 Dec 2019 | −18.4% |
| 20 Dec 2019 | −15.6% |
| 27 Dec 2019 | −9.6% |
| 3 Jan 2020 | −7.2% |
| 10 Jan 2020 | −7.0% |
| 17 Jan 2020 | −1.3% |
| 24 Jan 2020 | −5.1% |
| 31 Jan 2020 | −2.0% |
| 7 Feb 2020 | −0.4% |
| 14 Feb 2020 | +3.8% |
| 21 Feb 2020 | +2.9% |
| 28 Feb 2020 | −3.0% |
| 6 Mar 2020 | −1.1% |
| 13 Mar 2020 | +7.4% |
| 20 Mar 2020 | +10.9% |
| 27 Mar 2020 | +11.6% |
| 3 Apr 2020 | +20.5% |
| 9 Apr 2020 | +11.1% |
| 17 Apr 2020 | +6.3% |
| 24 Apr 2020 | +9.6% |
| 1 May 2020 | +2.8% |
| 8 May 2020 | +8.6% |
| 15 May 2020 | +3.9% |
| 22 May 2020 | +4.1% |
| 29 May 2020 | +14.5% |
| 5 Jun 2020 | +9.0% |
| 12 Jun 2020 | −4.2% |
| 19 Jun 2020 | −10.6% |
| 26 Jun 2020 | +6.3% |
| 2 Jul 2020 | −4.0% |
| 10 Jul 2020 | +8.2% |
| 17 Jul 2020 | +5.9% |
| 24 Jul 2020 | +2.8% |
| 31 Jul 2020 | +10.3% |
| 7 Aug 2020 | +8.8% |
| 14 Aug 2020 | +1.1% |
| 21 Aug 2020 | −2.2% |
| 28 Aug 2020 | −8.6% |
| 4 Sep 2020 | −6.2% |
| 11 Sep 2020 | −1.5% |
| 18 Sep 2020 | −0.2% |
| 25 Sep 2020 | −6.4% |
| 2 Oct 2020 | −17.4% |
| 9 Oct 2020 | −16.8% |
| 16 Oct 2020 | −16.4% |
| 23 Oct 2020 | −11.2% |
| 30 Oct 2020 | −9.2% |
| 6 Nov 2020 | −17.9% |
| 13 Nov 2020 | −11.4% |
| 20 Nov 2020 | −7.9% |
| 27 Nov 2020 | −5.1% |
| 4 Dec 2020 | −3.8% |
| 11 Dec 2020 | −2.7% |
| 18 Dec 2020 | −4.5% |
| 24 Dec 2020 | −4.9% |
| 31 Dec 2020 | +1.7% |
| 8 Jan 2021 | +6.8% |
| 15 Jan 2021 | +8.8% |
| 22 Jan 2021 | +8.5% |
| 29 Jan 2021 | +2.6% |
| 5 Feb 2021 | +10.3% |
| 12 Feb 2021 | +12.0% |
| 19 Feb 2021 | +6.0% |
| 26 Feb 2021 | +4.8% |
| 5 Mar 2021 | −0.7% |
| 12 Mar 2021 | −0.9% |
| 19 Mar 2021 | −3.4% |
| 26 Mar 2021 | +0.5% |
| 1 Apr 2021 | +5.5% |
| 9 Apr 2021 | +2.4% |
| 16 Apr 2021 | +2.4% |
| 23 Apr 2021 | +3.2% |
| 30 Apr 2021 | +6.0% |
| 7 May 2021 | +2.1% |
| 14 May 2021 | −1.1% |
| 21 May 2021 | +2.1% |
| 28 May 2021 | +2.3% |
| 4 Jun 2021 | +3.3% |
| 11 Jun 2021 | −0.3% |
| 18 Jun 2021 | +1.9% |
| 25 Jun 2021 | −2.4% |
| 2 Jul 2021 | −5.0% |
| 9 Jul 2021 | −8.6% |
| 16 Jul 2021 | −9.6% |
| 23 Jul 2021 | −15.8% |
| 30 Jul 2021 | −14.4% |
| 6 Aug 2021 | −13.0% |
| 13 Aug 2021 | −15.9% |
| 20 Aug 2021 | −11.1% |
| 27 Aug 2021 | −12.4% |
| 3 Sep 2021 | −8.8% |
| 10 Sep 2021 | −11.7% |
| 17 Sep 2021 | −13.9% |
| 24 Sep 2021 | −11.3% |
| 1 Oct 2021 | −6.1% |
| 8 Oct 2021 | −8.5% |
| 15 Oct 2021 | −11.0% |
| 22 Oct 2021 | −8.3% |
| 29 Oct 2021 | −7.6% |
| 5 Nov 2021 | −2.3% |
| 12 Nov 2021 | −0.2% |
| 19 Nov 2021 | −5.3% |
| 26 Nov 2021 | −7.8% |
| 3 Dec 2021 | −11.1% |
| 10 Dec 2021 | −11.0% |
| 17 Dec 2021 | +3.1% |
| 23 Dec 2021 | −1.8% |
| 31 Dec 2021 | −4.6% |
| 7 Jan 2022 | −9.8% |
| 14 Jan 2022 | −9.4% |
| 21 Jan 2022 | −11.4% |
| 28 Jan 2022 | −13.4% |
| 4 Feb 2022 | −17.5% |
| 11 Feb 2022 | −12.6% |
| 18 Feb 2022 | −12.6% |
| 25 Feb 2022 | −7.4% |
| 4 Mar 2022 | −5.0% |
| 11 Mar 2022 | −5.1% |
| 18 Mar 2022 | −17.0% |
| 25 Mar 2022 | −25.8% |
| 1 Apr 2022 | −25.9% |
| 8 Apr 2022 | −17.7% |
| 14 Apr 2022 | −17.0% |
| 22 Apr 2022 | −15.7% |
| 29 Apr 2022 | −17.9% |
| 6 May 2022 | −13.3% |
| 13 May 2022 | −18.0% |
| 20 May 2022 | −14.1% |
| 27 May 2022 | −21.2% |
| 3 Jun 2022 | −22.0% |
| 10 Jun 2022 | −21.7% |
| 17 Jun 2022 | −17.7% |
| 24 Jun 2022 | −7.4% |
| 1 Jul 2022 | −7.1% |
| 8 Jul 2022 | −12.2% |
| 15 Jul 2022 | −13.1% |
| 22 Jul 2022 | −15.8% |
| 29 Jul 2022 | −12.4% |
| 5 Aug 2022 | −23.5% |
| 12 Aug 2022 | −22.3% |
| 19 Aug 2022 | −29.4% |
| 26 Aug 2022 | −18.0% |
| 2 Sep 2022 | −26.5% |
| 9 Sep 2022 | −27.5% |
| 16 Sep 2022 | −34.9% |
| 23 Sep 2022 | −34.2% |
| 30 Sep 2022 | −36.2% |
| 7 Oct 2022 | −39.1% |
| 14 Oct 2022 | −42.5% |
| 21 Oct 2022 | −44.6% |
| 28 Oct 2022 | −37.7% |
| 4 Nov 2022 | −27.1% |
| 11 Nov 2022 | −20.2% |
| 18 Nov 2022 | −18.9% |
| 25 Nov 2022 | −22.6% |
| 2 Dec 2022 | −12.6% |
| 9 Dec 2022 | −14.9% |
| 16 Dec 2022 | −7.0% |
| 23 Dec 2022 | −3.5% |
| 30 Dec 2022 | +2.0% |
| 6 Jan 2023 | +22.1% |
| 13 Jan 2023 | +46.2% |
| 20 Jan 2023 | +72.1% |
| 27 Jan 2023 | +48.3% |
| 3 Feb 2023 | +38.6% |
| 10 Feb 2023 | +18.2% |
| 17 Feb 2023 | +26.5% |
| 24 Feb 2023 | +15.9% |
| 3 Mar 2023 | +16.8% |
| 10 Mar 2023 | +16.6% |
| 17 Mar 2023 | +22.4% |
| 24 Mar 2023 | +19.1% |
| 31 Mar 2023 | +14.6% |
| 6 Apr 2023 | −0.9% |
| 14 Apr 2023 | −13.4% |
| 21 Apr 2023 | −15.9% |
| 28 Apr 2023 | −16.6% |
| 5 May 2023 | −14.1% |
| 12 May 2023 | −16.6% |
| 19 May 2023 | −22.1% |
| 26 May 2023 | −14.0% |
| 2 Jun 2023 | −8.9% |
| 9 Jun 2023 | −4.2% |
| 16 Jun 2023 | −0.3% |
| 23 Jun 2023 | +9.6% |
| 30 Jun 2023 | +9.2% |
| 7 Jul 2023 | +17.3% |
| 14 Jul 2023 | +32.3% |
| 21 Jul 2023 | +20.6% |
| 28 Jul 2023 | +24.2% |
| 4 Aug 2023 | +22.6% |
| 11 Aug 2023 | +27.6% |
| 18 Aug 2023 | +32.7% |
| 25 Aug 2023 | +28.2% |
| 1 Sep 2023 | +20.6% |
| 8 Sep 2023 | +1.4% |
| 15 Sep 2023 | −0.9% |
| 22 Sep 2023 | −11.5% |
| 29 Sep 2023 | −11.2% |
| 6 Oct 2023 | −17.5% |
| 13 Oct 2023 | −28.0% |
| 20 Oct 2023 | −26.4% |
| 27 Oct 2023 | −23.5% |
| 3 Nov 2023 | −28.0% |
| 10 Nov 2023 | −31.8% |
| 17 Nov 2023 | −31.5% |
| 24 Nov 2023 | −29.4% |
| 1 Dec 2023 | −27.0% |
| 8 Dec 2023 | −10.1% |
| 15 Dec 2023 | −12.3% |
| 22 Dec 2023 | −1.8% |
| 29 Dec 2023 | −2.7% |
| 5 Jan 2024 | +4.6% |
| 12 Jan 2024 | +7.0% |
| 19 Jan 2024 | −1.6% |
| 26 Jan 2024 | −13.3% |
| 2 Feb 2024 | −14.9% |
| 9 Feb 2024 | −4.1% |
| 16 Feb 2024 | −1.6% |
| 23 Feb 2024 | −10.9% |
| 1 Mar 2024 | −13.1% |
| 8 Mar 2024 | −21.2% |
| 15 Mar 2024 | −30.5% |
| 22 Mar 2024 | −36.3% |
| 28 Mar 2024 | −31.6% |
| 5 Apr 2024 | −37.0% |
| 12 Apr 2024 | −39.1% |
| 19 Apr 2024 | −34.3% |
| 26 Apr 2024 | −29.1% |
| 3 May 2024 | −26.5% |
| 10 May 2024 | −29.4% |
| 17 May 2024 | −29.2% |
| 24 May 2024 | −26.1% |
| 31 May 2024 | −26.3% |
| 7 Jun 2024 | −5.9% |
| 14 Jun 2024 | +5.6% |
| 21 Jun 2024 | +4.5% |
| 28 Jun 2024 | −5.0% |
| 5 Jul 2024 | −0.9% |
| 12 Jul 2024 | +23.3% |
| 19 Jul 2024 | +29.8% |
| 26 Jul 2024 | +35.6% |
| 2 Aug 2024 | +32.0% |
| 9 Aug 2024 | +33.9% |
| 16 Aug 2024 | +14.6% |
| 23 Aug 2024 | +20.4% |
| 30 Aug 2024 | +24.3% |
| 6 Sep 2024 | −5.5% |
| 13 Sep 2024 | −8.7% |
| 20 Sep 2024 | +1.0% |
| 27 Sep 2024 | +1.3% |
| 4 Oct 2024 | −4.4% |
| 11 Oct 2024 | −15.8% |
| 18 Oct 2024 | −17.7% |
| 25 Oct 2024 | −26.7% |
| 1 Nov 2024 | −19.0% |
| 8 Nov 2024 | −15.6% |
| 15 Nov 2024 | −15.3% |
| 22 Nov 2024 | −16.7% |
| 29 Nov 2024 | −24.7% |
| 6 Dec 2024 | −29.3% |
| 13 Dec 2024 | −32.2% |
| 20 Dec 2024 | −35.1% |
| 27 Dec 2024 | −29.3% |
| 3 Jan 2025 | −22.0% |
| 10 Jan 2025 | −14.5% |
| 17 Jan 2025 | −22.5% |
| 24 Jan 2025 | −21.9% |
| 31 Jan 2025 | −26.0% |
| 7 Feb 2025 | −36.5% |
| 14 Feb 2025 | −36.8% |
| 21 Feb 2025 | −33.7% |
| 28 Feb 2025 | −27.7% |
| 7 Mar 2025 | −13.6% |
| 14 Mar 2025 | −18.7% |
| 21 Mar 2025 | −21.9% |
| 28 Mar 2025 | −23.9% |
| 4 Apr 2025 | −21.7% |
| 11 Apr 2025 | −46.8% |
| 17 Apr 2025 | −50.1% |
| 25 Apr 2025 | −45.6% |
| 2 May 2025 | −44.0% |
| 9 May 2025 | −36.4% |
| 16 May 2025 | −30.2% |
| 23 May 2025 | −36.2% |
| 30 May 2025 | −40.9% |
| 6 Jun 2025 | −53.9% |
| 13 Jun 2025 | −45.0% |
| 20 Jun 2025 | −49.6% |
| 27 Jun 2025 | −55.9% |
| 3 Jul 2025 | −55.4% |
| 11 Jul 2025 | −20.2% |
| 18 Jul 2025 | −11.2% |
| 25 Jul 2025 | −14.5% |
| 1 Aug 2025 | −28.7% |
| 8 Aug 2025 | −27.8% |
| 15 Aug 2025 | −26.1% |
| 22 Aug 2025 | −18.4% |
| 29 Aug 2025 | −11.3% |
| 5 Sep 2025 | +2.3% |
| 12 Sep 2025 | −10.7% |
| 19 Sep 2025 | +1.9% |
| 26 Sep 2025 | +12.2% |
| 3 Oct 2025 | +6.7% |
| 10 Oct 2025 | +7.3% |
| 17 Oct 2025 | +18.2% |
| 24 Oct 2025 | +12.3% |
| 31 Oct 2025 | +22.7% |
| 7 Nov 2025 | +20.7% |
| 14 Nov 2025 | +13.3% |
| 21 Nov 2025 | −0.7% |
| 28 Nov 2025 | −1.9% |
| 5 Dec 2025 | −1.9% |
| 12 Dec 2025 | +21.0% |
| 19 Dec 2025 | +25.8% |
| 26 Dec 2025 | +21.4% |
| 2 Jan 2026 | +13.4% |
| 9 Jan 2026 | +53.0% |
| 16 Jan 2026 | +53.2% |
| 23 Jan 2026 | +56.6% |
| 30 Jan 2026 | +64.2% |
| 6 Feb 2026 | +65.8% |
| 13 Feb 2026 | +69.7% |
| 20 Feb 2026 | +93.5% |
| 27 Feb 2026 | +87.4% |
| 6 Mar 2026 | +64.1% |
| 13 Mar 2026 | +35.4% |
| 20 Mar 2026 | +20.8% |
| 27 Mar 2026 | +30.2% |
| 2 Apr 2026 | +38.4% |
| 10 Apr 2026 | +0.0% |
| 17 Apr 2026 | +0.1% |
| 24 Apr 2026 | −6.2% |
| 1 May 2026 | −10.9% |
| 8 May 2026 | −23.0% |
| 15 May 2026 | −33.6% |
| 22 May 2026 | −29.6% |
| 29 May 2026 | −30.4% |
| 5 Jun 2026 | −17.9% |
| 12 Jun 2026 | −11.9% |
| 18 Jun 2026 | −3.8% |
| 26 Jun 2026 | −4.9% |
| 2 Jul 2026 | −14.3% |
| 10 Jul 2026 | −9.0% |
| 17 Jul 2026 | +3.3% |
| 24 Jul 2026 | −5.0% |
| 31 Jul 2026 | +22.7% |
| 7 Aug 2026 | +21.9% |
| 14 Aug 2026 | +37.2% |
| 21 Aug 2026 | +31.6% |
| 28 Aug 2026 | +28.3% |
| 4 Sep 2026 | +28.5% |
| 11 Sep 2026 | +26.4% |
| 18 Sep 2026 | +37.6% |
| 25 Sep 2026 | +37.8% |
| 2 Oct 2026 | +26.7% |
| 9 Oct 2026 | +20.1% |
| 16 Oct 2026 | +12.3% |
| 23 Oct 2026 | +26.8% |
| 30 Oct 2026 | −3.0% |
| 4 Nov 2026 | +9.5% |
Over the last 10 years the share price moved −43% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What dividend does Neogen pay?
Neogen Corporation pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.
Which stock lists is Neogen on?
Neogen is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.
Is Neogen profitable?
Neogen Corporation posted a net loss of $11.9 M in the Aug 2026 quarter. The full FY26 year was a loss of $7.9 M. That loss is 5.3% of the quarter's revenue. The same quarter a year earlier earned $36.3 M. 11 of the last 12 reported quarters were loss-making.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
Aug 2026 profit was −$11.9 M, −132.8% on a year earlier.
FY26 profit −$7.9 M
- Net profit −$7.9 M
| Quarter | Net profit |
|---|---|
| FY21 | $60.9 M |
| FY22 | $48.3 M |
| FY23 | −$22.9 M |
| FY24 | −$9.4 M |
| FY25 | −$1.1 B |
| FY26 | −$7.9 M |
Growth on a year earlier
- Growth on a year earlier −147.3%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | −20.7% |
| FY23 | −147.3% |
| FY24 | – |
| FY25 | – |
| FY26 | – |
Aug 2026: −$11.9 M (−132.8% on a year earlier)
- Net profit (quarterly) −$11.9 M
| Quarter | Net profit (quarterly) |
|---|---|
| Nov 2023 | −$3.5 M |
| Feb 2024 | −$2.0 M |
| May 2024 | −$5.4 M |
| Aug 2024 | −$12.6 M |
| Nov 2024 | −$456 M |
| Feb 2025 | −$10.9 M |
| May 2025 | −$612 M |
| Aug 2025 | $36.3 M |
| Nov 2025 | −$15.9 M |
| Feb 2026 | −$17.0 M |
| May 2026 | −$11.3 M |
| Aug 2026 | −$11.9 M |
Growth on a year earlier
- Growth on a year earlier −132.8%
| Quarter | Growth on a year earlier |
|---|---|
| Nov 2023 | – |
| Feb 2024 | −124.7% |
| May 2024 | −197.2% |
| Aug 2024 | −938.9% |
| Nov 2024 | – |
| Feb 2025 | – |
| May 2025 | – |
| Aug 2025 | – |
| Nov 2025 | – |
| Feb 2026 | – |
| May 2026 | – |
| Aug 2026 | −132.8% |
How much revenue does Neogen make, and is it growing?
Neogen Corporation reported $223 M of revenue in the Aug 2026 quarter, +6.5% on the same quarter a year earlier. Over 5 years it has grown 13.2% a year on average. The last full year, FY26, came in at $870 M. The last four reported quarters add to $884 M.
Revenue is everything the company billed its customers in the period.
FY26 revenue was $870 M, −2.7% on the year before.
FY26 revenue $870 M (−2.7% on the year before), 13.2% a year over 5 years
- Revenue $870 M
| Quarter | Revenue |
|---|---|
| FY21 | $468 M |
| FY22 | $527 M |
| FY23 | $822 M |
| FY24 | $924 M |
| FY25 | $895 M |
| FY26 | $870 M |
Growth on a year earlier
- Growth on a year earlier −2.7%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | 12.5% |
| FY23 | 56% |
| FY24 | 12.4% |
| FY25 | −3.2% |
| FY26 | −2.7% |
Aug 2026: $223 M (+6.5% on a year earlier)
- Revenue (quarterly) $223 M
| Quarter | Revenue (quarterly) |
|---|---|
| Nov 2023 | $230 M |
| Feb 2024 | $229 M |
| May 2024 | $237 M |
| Aug 2024 | $217 M |
| Nov 2024 | $231 M |
| Feb 2025 | $221 M |
| May 2025 | $226 M |
| Aug 2025 | $209 M |
| Nov 2025 | $225 M |
| Feb 2026 | $211 M |
| May 2026 | $225 M |
| Aug 2026 | $223 M |
Growth on a year earlier
- Growth on a year earlier 6.5%
| Quarter | Growth on a year earlier |
|---|---|
| Nov 2023 | −0.2% |
| Feb 2024 | 4.8% |
| May 2024 | −2.1% |
| Aug 2024 | −5.3% |
| Nov 2024 | 0.7% |
| Feb 2025 | −3.4% |
| May 2025 | −4.8% |
| Aug 2025 | −3.6% |
| Nov 2025 | −2.8% |
| Feb 2026 | −4.4% |
| May 2026 | −0.1% |
| Aug 2026 | 6.5% |
Recent pace: the last four quarters grew −0.2% on average, against 13.2% a year over the longer run, so this year is growing slower than its own long-run rate.
Is growth speeding up? Revenue over the last 12 months grew −0.3%, against −1.6% a year over the last 8 quarters (stabilising).
How much of every $100 of sales does Neogen keep?
Neogen Corporation's operating margin was −0.8% in the Aug 2026 quarter, 6.9 percentage points higher than the same quarter a year ago. Across 6 years it has been between −2.5% and 16.0%. The latest quarter is within that range.
Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
Why the margin moved: operating margin changed +6.9 percentage points on the year while gross margin changed +2.0 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.
FY26: −2.5%, within a range of −2.5% to 16.0% over 6 years
- Operating margin −2.5%
| Quarter | Operating margin |
|---|---|
| FY21 | 15.8% |
| FY22 | 16% |
| FY23 | 4.6% |
| FY24 | 6.3% |
| FY25 | 0% |
| FY26 | −2.5% |
Change on the year before (points)
- Change on the year before (points) −2.5 pts
| Quarter | Change on the year before (points) |
|---|---|
| FY21 | – |
| FY22 | +0.2 pts |
| FY23 | −11.4 pts |
| FY24 | +1.7 pts |
| FY25 | −6.3 pts |
| FY26 | −2.5 pts |
Aug 2026: operating margin −0.8% (+6.9 points on a year earlier)
- Operating margin −0.8%
| Quarter | Operating margin |
|---|---|
| Nov 2023 | 6.3% |
| Feb 2024 | 5.3% |
| May 2024 | 5.5% |
| Aug 2024 | 1% |
| Nov 2024 | 1.7% |
| Feb 2025 | 2.4% |
| May 2025 | −5% |
| Aug 2025 | −7.7% |
| Nov 2025 | −2.4% |
| Feb 2026 | −1.6% |
| May 2026 | 1.4% |
| Aug 2026 | −0.8% |
Change on a year earlier (points)
- Change on a year earlier (points) +6.9 pts
| Quarter | Change on a year earlier (points) |
|---|---|
| Nov 2023 | −7.4 pts |
| Feb 2024 | −1.9 pts |
| May 2024 | −31.1 pts |
| Aug 2024 | −7.9 pts |
| Nov 2024 | −4.6 pts |
| Feb 2025 | −2.9 pts |
| May 2025 | −10.5 pts |
| Aug 2025 | −8.7 pts |
| Nov 2025 | −4.1 pts |
| Feb 2026 | −4.0 pts |
| May 2026 | +6.4 pts |
| Aug 2026 | +6.9 pts |
Is Neogen's profit turning into cash?
Over the last 2 years, 137% of Neogen Corporation's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in $83.2 M of operating cash against −$7.9 M of profit. After $51.3 M of spending on assets, $31.9 M was left over as free cash.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
FY26: operating cash $83.2 M against profit −$7.9 M; 137% of 2 years' profit came in as cash
- Operating cash $83.2 M
- Net profit −$7.9 M
- Free cash $31.9 M
| Quarter | Operating cash | Net profit | Free cash |
|---|---|---|---|
| FY21 | $81.1 M | $60.9 M | $54.4 M |
| FY22 | $68.0 M | $48.3 M | $43.6 M |
| FY23 | $41.0 M | −$22.9 M | −$24.7 M |
| FY24 | $35.3 M | −$9.4 M | −$76.1 M |
| FY25 | $58.2 M | −$1.1 B | −$46.4 M |
| FY26 | $83.2 M | −$7.9 M | $31.9 M |
Aug 2026: operating cash $12.9 M
- Operating cash (quarterly) $12.9 M
| Quarter | Operating cash (quarterly) |
|---|---|
| Nov 2023 | $15.7 M |
| Feb 2024 | −$30.2 M |
| May 2024 | $26.7 M |
| Aug 2024 | −$17.9 M |
| Nov 2024 | $40.3 M |
| Feb 2025 | $19.5 M |
| May 2025 | $16.4 M |
| Aug 2025 | $10.8 M |
| Nov 2025 | $19.4 M |
| Feb 2026 | $22.7 M |
| May 2026 | $30.2 M |
| Aug 2026 | $12.9 M |
Operating cash as % of profit
- Operating cash as % of profit 30%
| Quarter | Operating cash as % of profit |
|---|---|
| Nov 2023 | – |
| Feb 2024 | – |
| May 2024 | – |
| Aug 2024 | – |
| Nov 2024 | – |
| Feb 2025 | – |
| May 2025 | – |
| Aug 2025 | 30% |
| Nov 2025 | – |
| Feb 2026 | – |
| May 2026 | – |
| Aug 2026 | – |
Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.
What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.
Where does Neogen's cash go?
Neogen Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $267 M on assets over the last 3 years. Averaged over those years that is 10.2% of FY26 revenue a year.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.
Spending on assets: $267 M over the last 3 years.
FY26: capex $51.3 M, down from the year before
- Capex $51.3 M
| Quarter | Capex |
|---|---|
| FY21 | $26.7 M |
| FY22 | $24.4 M |
| FY23 | $65.8 M |
| FY24 | $111 M |
| FY25 | $105 M |
| FY26 | $51.3 M |
Aug 2026: capex $8.2 M in the quarter
- Capex (quarterly) $8.2 M
| Quarter | Capex (quarterly) |
|---|---|
| Nov 2023 | $24.4 M |
| Feb 2024 | $32.1 M |
| May 2024 | $24.3 M |
| Aug 2024 | $38.4 M |
| Nov 2024 | $17.2 M |
| Feb 2025 | $32.9 M |
| May 2025 | $16.1 M |
| Aug 2025 | $24.0 M |
| Nov 2025 | $11.7 M |
| Feb 2026 | $11.6 M |
| May 2026 | $4.0 M |
| Aug 2026 | $8.2 M |
Free cash
- Free cash $4.7 M
| Quarter | Free cash |
|---|---|
| Nov 2023 | −$8.7 M |
| Feb 2024 | −$62.3 M |
| May 2024 | $2.5 M |
| Aug 2024 | −$56.3 M |
| Nov 2024 | $23.1 M |
| Feb 2025 | −$13.4 M |
| May 2025 | $0.3 M |
| Aug 2025 | −$13.2 M |
| Nov 2025 | $7.8 M |
| Feb 2026 | $11.1 M |
| May 2026 | $26.2 M |
| Aug 2026 | $4.7 M |
In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.
What is Neogen's P/E ratio, and how does it compare with its own history?
Neogen Corporation's P/E is 5,023.3×, near the high end of its own history: higher than 83% of past readings. Its usual P/E (the middle reading) is 472.6×, over 2.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.
P/E 5,023.3× against a usual 472.6×: near the high end of its own history: higher than 83% of past readings
- P/E 1,417.7×
- Median 472.6×
| Week | P/E | Median |
|---|---|---|
| 4 Mar 2022 | 77.8× | 472.6× |
| 11 Mar 2022 | 73.5× | 472.6× |
| 18 Mar 2022 | 76.8× | 472.6× |
| 25 Mar 2022 | 67.9× | 472.6× |
| 1 Apr 2022 | 68.5× | 472.6× |
| 8 Apr 2022 | 68.2× | 472.6× |
| 14 Apr 2022 | 65.3× | 472.6× |
| 22 Apr 2022 | 62.1× | 472.6× |
| 29 Apr 2022 | 57.4× | 472.6× |
| 6 May 2022 | 60.4× | 472.6× |
| 13 May 2022 | 57.6× | 472.6× |
| 20 May 2022 | 57.9× | 472.6× |
| 27 May 2022 | 58.0× | 472.6× |
| 3 Jun 2022 | 58.1× | 472.6× |
| 10 Jun 2022 | 53.5× | 472.6× |
| 17 Jun 2022 | 50.9× | 472.6× |
| 24 Jun 2022 | 54.8× | 472.6× |
| 1 Jul 2022 | 54.1× | 472.6× |
| 8 Jul 2022 | 52.1× | 472.6× |
| 15 Jul 2022 | 50.1× | 472.6× |
| 22 Jul 2022 | 49.0× | 472.6× |
| 29 Jul 2022 | 51.5× | 472.6× |
| 5 Aug 2022 | 47.7× | 472.6× |
| 12 Aug 2022 | 49.6× | 472.6× |
| 19 Aug 2022 | 46.8× | 472.6× |
| 26 Aug 2022 | 47.3× | 472.6× |
| 2 Sep 2022 | 53.5× | 472.6× |
| 9 Sep 2022 | 54.8× | 472.6× |
| 16 Sep 2022 | 47.8× | 472.6× |
| 23 Sep 2022 | 43.9× | 472.6× |
| 30 Sep 2022 | 41.5× | 472.6× |
| 7 Oct 2022 | 37.6× | 472.6× |
| 14 Oct 2022 | 33.6× | 472.6× |
| 21 Oct 2022 | 32.7× | 472.6× |
| 28 Oct 2022 | 39.0× | 472.6× |
| 4 Nov 2022 | 40.6× | 472.6× |
| 11 Nov 2022 | 48.3× | 472.6× |
| 18 Nov 2022 | 46.7× | 472.6× |
| 25 Nov 2022 | 48.3× | 472.6× |
| 2 Dec 2022 | 382.1× | 472.6× |
| 9 Dec 2022 | 351.2× | 472.6× |
| 16 Dec 2022 | 346.1× | 472.6× |
| 23 Dec 2022 | 345.8× | 472.6× |
| 30 Dec 2022 | 354.2× | 472.6× |
| 6 Jan 2023 | 380.7× | 472.6× |
| 13 Jan 2023 | 415.4× | 472.6× |
| 20 Jan 2023 | 456.3× | 472.6× |
| 27 Jan 2023 | 466.1× | 472.6× |
| 3 Feb 2023 | 471.9× | 472.6× |
| 10 Feb 2023 | 456.7× | 472.6× |
| 17 Feb 2023 | 473.3× | 472.6× |
| 24 Feb 2023 | 432.8× | 472.6× |
| 3 Mar 2023 | 615.5× | 472.6× |
| 10 Mar 2023 | 558.7× | 472.6× |
| 17 Mar 2023 | 596.1× | 472.6× |
| 24 Mar 2023 | 587.4× | 472.6× |
| 31 Mar 2023 | 597.4× | 472.6× |
| 6 Apr 2023 | 551.9× | 472.6× |
| 14 Apr 2023 | 519.4× | 472.6× |
| 21 Apr 2023 | 558.4× | 472.6× |
| 28 Apr 2023 | 555.5× | 472.6× |
| 5 May 2023 | 562.6× | 472.6× |
| 12 May 2023 | 534.2× | 472.6× |
| 19 May 2023 | 530.0× | 472.6× |
| 26 May 2023 | 551.9× | 472.6× |
| 2 Jun 2023 | 597.1× | 472.6× |
| 9 Jun 2023 | 599.0× | 472.6× |
| 16 Jun 2023 | 670.0× | 472.6× |
| 23 Jun 2023 | 699.7× | 472.6× |
| 30 Jun 2023 | 701.6× | 472.6× |
| 7 Jul 2023 | 687.1× | 472.6× |
| 14 Jul 2023 | 733.5× | 472.6× |
| 21 Jul 2023 | 727.7× | 472.6× |
| 28 Jul 2023 | 744.8× | 472.6× |
| 4 Aug 2023 | 736.5× | 472.6× |
| 11 Aug 2023 | 725.8× | 472.6× |
| 18 Aug 2023 | 725.8× | 472.6× |
| 25 Aug 2023 | 733.9× | 472.6× |
| 1 Sep 2023 | 752.6× | 472.6× |
| 8 Sep 2023 | 629.0× | 472.6× |
| 15 Sep 2023 | 669.7× | 472.6× |
| 22 Sep 2023 | 614.8× | 472.6× |
| 29 Sep 2023 | 598.1× | 472.6× |
| 1 Dec 2023 | 342.0× | 472.6× |
| 8 Dec 2023 | 356.5× | 472.6× |
| 15 Dec 2023 | 380.8× | 472.6× |
| 22 Dec 2023 | 404.5× | 472.6× |
| 29 Dec 2023 | 394.3× | 472.6× |
| 5 Jan 2024 | 381.4× | 472.6× |
| 12 Jan 2024 | 356.5× | 472.6× |
| 19 Jan 2024 | 333.3× | 472.6× |
| 26 Jan 2024 | 316.5× | 472.6× |
| 2 Feb 2024 | 306.5× | 472.6× |
| 9 Feb 2024 | 324.5× | 472.6× |
| 16 Feb 2024 | 345.9× | 472.6× |
| 23 Feb 2024 | 332.6× | 472.6× |
| 1 Mar 2024 | 1,417.7× | 472.6× |
| 8 Mar 2024 | 1,417.7× | 472.6× |
| 15 Mar 2024 | 1,417.7× | 472.6× |
| 22 Mar 2024 | 1,417.7× | 472.6× |
| 28 Mar 2024 | 1,417.7× | 472.6× |
| 5 Apr 2024 | 1,417.7× | 472.6× |
| 12 Apr 2024 | 1,417.7× | 472.6× |
| 19 Apr 2024 | 1,417.7× | 472.6× |
| 26 Apr 2024 | 1,417.7× | 472.6× |
| 3 May 2024 | 1,417.7× | 472.6× |
| 10 May 2024 | 1,417.7× | 472.6× |
| 17 May 2024 | 1,417.7× | 472.6× |
| 24 May 2024 | 1,417.7× | 472.6× |
| 31 May 2024 | 1,417.7× | 472.6× |
| 7 Jun 2024 | 1,417.7× | 472.6× |
| 14 Jun 2024 | 1,417.7× | 472.6× |
| 21 Jun 2024 | 1,417.7× | 472.6× |
| 28 Jun 2024 | 1,417.7× | 472.6× |
| 5 Jul 2024 | 1,417.7× | 472.6× |
| 12 Jul 2024 | 1,417.7× | 472.6× |
| 19 Jul 2024 | 1,417.7× | 472.6× |
| 26 Jul 2024 | 1,417.7× | 472.6× |
| 2 Aug 2024 | 1,417.7× | 472.6× |
| 9 Aug 2024 | 1,417.7× | 472.6× |
| 16 Aug 2024 | 1,417.7× | 472.6× |
| 23 Aug 2024 | 1,417.7× | 472.6× |
| 30 Aug 2024 | 1,417.7× | 472.6× |
| 6 Sep 2024 | 1,417.7× | 472.6× |
| 13 Sep 2024 | 1,417.7× | 472.6× |
| 20 Sep 2024 | 1,417.7× | 472.6× |
| 27 Sep 2024 | 1,417.7× | 472.6× |
| 4 Oct 2024 | 1,417.7× | 472.6× |
Earnings per share, 12 months
- Earnings per share, 12 months $0.003
| Week | Earnings per share, 12 months |
|---|---|
| 4 Mar 2022 | – |
| 11 Mar 2022 | – |
| 18 Mar 2022 | – |
| 25 Mar 2022 | $0.46 |
| 1 Apr 2022 | $0.46 |
| 8 Apr 2022 | $0.46 |
| 14 Apr 2022 | $0.46 |
| 22 Apr 2022 | $0.46 |
| 29 Apr 2022 | $0.46 |
| 6 May 2022 | $0.46 |
| 13 May 2022 | $0.46 |
| 20 May 2022 | $0.46 |
| 27 May 2022 | $0.46 |
| 3 Jun 2022 | $0.46 |
| 10 Jun 2022 | $0.46 |
| 17 Jun 2022 | $0.46 |
| 24 Jun 2022 | $0.45 |
| 1 Jul 2022 | $0.45 |
| 8 Jul 2022 | $0.45 |
| 15 Jul 2022 | $0.45 |
| 22 Jul 2022 | $0.45 |
| 29 Jul 2022 | $0.45 |
| 5 Aug 2022 | $0.45 |
| 12 Aug 2022 | $0.45 |
| 19 Aug 2022 | $0.45 |
| 26 Aug 2022 | $0.45 |
| 2 Sep 2022 | $0.45 |
| 9 Sep 2022 | $0.45 |
| 16 Sep 2022 | $0.45 |
| 23 Sep 2022 | $0.45 |
| 30 Sep 2022 | $0.34 |
| 7 Oct 2022 | $0.34 |
| 14 Oct 2022 | $0.34 |
| 21 Oct 2022 | $0.34 |
| 28 Oct 2022 | $0.34 |
| 4 Nov 2022 | $0.34 |
| 11 Nov 2022 | $0.34 |
| 18 Nov 2022 | $0.34 |
| 25 Nov 2022 | $0.34 |
| 2 Dec 2022 | $0.34 |
| 9 Dec 2022 | $0.34 |
| 16 Dec 2022 | $0.34 |
| 23 Dec 2022 | $0.34 |
| 30 Dec 2022 | $0.04 |
| 6 Jan 2023 | $0.04 |
| 13 Jan 2023 | $0.04 |
| 20 Jan 2023 | $0.04 |
| 27 Jan 2023 | $0.04 |
| 3 Feb 2023 | $0.04 |
| 10 Feb 2023 | $0.04 |
| 17 Feb 2023 | $0.04 |
| 24 Feb 2023 | $0.04 |
| 3 Mar 2023 | $0.04 |
| 10 Mar 2023 | $0.04 |
| 17 Mar 2023 | $0.04 |
| 24 Mar 2023 | $0.04 |
| 31 Mar 2023 | $0.03 |
| 6 Apr 2023 | $0.03 |
| 14 Apr 2023 | $0.03 |
| 21 Apr 2023 | $0.03 |
| 28 Apr 2023 | $0.03 |
| 5 May 2023 | $0.03 |
| 12 May 2023 | $0.03 |
| 19 May 2023 | $0.03 |
| 26 May 2023 | $0.03 |
| 2 Jun 2023 | $0.03 |
| 9 Jun 2023 | $0.03 |
| 16 Jun 2023 | $0.03 |
| 23 Jun 2023 | $0.03 |
| 30 Jun 2023 | $0.03 |
| 7 Jul 2023 | $0.03 |
| 14 Jul 2023 | $0.03 |
| 21 Jul 2023 | $0.03 |
| 28 Jul 2023 | $0.03 |
| 4 Aug 2023 | $0.03 |
| 11 Aug 2023 | $0.03 |
| 18 Aug 2023 | $0.03 |
| 25 Aug 2023 | $0.03 |
| 1 Sep 2023 | $0.03 |
| 8 Sep 2023 | $0.03 |
| 15 Sep 2023 | $0.03 |
| 22 Sep 2023 | $0.03 |
| 29 Sep 2023 | $0.03 |
| 1 Dec 2023 | $0.03 |
| 8 Dec 2023 | $0.03 |
| 15 Dec 2023 | $0.03 |
| 22 Dec 2023 | $0.03 |
| 29 Dec 2023 | $0.05 |
| 5 Jan 2024 | $0.05 |
| 12 Jan 2024 | $0.05 |
| 19 Jan 2024 | $0.05 |
| 26 Jan 2024 | $0.05 |
| 2 Feb 2024 | $0.05 |
| 9 Feb 2024 | $0.05 |
| 16 Feb 2024 | $0.05 |
| 23 Feb 2024 | $0.05 |
| 1 Mar 2024 | $0.05 |
| 8 Mar 2024 | $0.05 |
| 15 Mar 2024 | $0.05 |
| 22 Mar 2024 | $0.05 |
| 28 Mar 2024 | $0.00 |
| 5 Apr 2024 | $0.00 |
| 12 Apr 2024 | $0.00 |
| 19 Apr 2024 | $0.00 |
| 26 Apr 2024 | $0.00 |
| 3 May 2024 | $0.00 |
| 10 May 2024 | $0.00 |
| 17 May 2024 | $0.00 |
| 24 May 2024 | $0.00 |
| 31 May 2024 | $0.00 |
| 7 Jun 2024 | $0.00 |
| 14 Jun 2024 | $0.00 |
| 21 Jun 2024 | $0.00 |
| 28 Jun 2024 | $0.00 |
| 5 Jul 2024 | $0.00 |
| 12 Jul 2024 | $0.00 |
| 19 Jul 2024 | $0.00 |
| 26 Jul 2024 | $0.00 |
| 2 Aug 2024 | $0.00 |
| 9 Aug 2024 | $0.00 |
| 16 Aug 2024 | $0.00 |
| 23 Aug 2024 | $0.00 |
| 30 Aug 2024 | $0.00 |
| 6 Sep 2024 | $0.00 |
| 13 Sep 2024 | $0.00 |
| 20 Sep 2024 | $0.00 |
| 27 Sep 2024 | $0.00 |
| 4 Oct 2024 | $0.00 |
PEG 3.73 at the Aug 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
- PEG 3.73×
- PEG = 1.0 1.00×
| Quarter | PEG | PEG = 1.0 |
|---|---|---|
| Aug 2021 | 6.00× | 1.00× |
| Nov 2021 | 6.00× | 1.00× |
| Feb 2022 | 6.00× | 1.00× |
| May 2022 | 6.00× | 1.00× |
| Aug 2022 | 6.00× | 1.00× |
| Nov 2022 | 6.00× | 1.00× |
| Feb 2023 | 6.00× | 1.00× |
| May 2023 | 6.00× | 1.00× |
| Aug 2023 | 6.00× | 1.00× |
| Nov 2023 | 6.00× | 1.00× |
| Feb 2024 | 6.00× | 1.00× |
| May 2024 | 6.00× | 1.00× |
| Aug 2024 | 6.00× | 1.00× |
| Nov 2024 | 6.00× | 1.00× |
| Feb 2025 | 6.00× | 1.00× |
| May 2025 | 6.00× | 1.00× |
| Aug 2025 | 6.00× | 1.00× |
| Nov 2025 | 1.85× | 1.00× |
| Feb 2026 | 4.04× | 1.00× |
| May 2026 | 3.54× | 1.00× |
| Aug 2026 | 3.73× | 1.00× |
In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.
Is the Neogen business getting better or worse?
Neogen Corporation's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Growth year by year: revenue −2.7% in FY26
- Revenue growth −2.7%
| Quarter | Revenue growth |
|---|---|
| FY21 | – |
| FY22 | 12.5% |
| FY23 | 56% |
| FY24 | 12.4% |
| FY25 | −3.2% |
| FY26 | −2.7% |
Profit growth, EPS growth
- Profit growth −147.3%
- EPS growth −127%
| Quarter | Profit growth | EPS growth |
|---|---|---|
| FY21 | – | – |
| FY22 | −20.7% | −21.3% |
| FY23 | −147.3% | −127% |
| FY24 | – | – |
| FY25 | – | – |
| FY26 | – | – |
Three growth lines over twelve quarters: revenue stabilising
- Revenue −0.3%
| Quarter | Revenue |
|---|---|
| Nov 2023 | 45.7% |
| Feb 2024 | 28.9% |
| May 2024 | 12.4% |
| Aug 2024 | −0.7% |
| Nov 2024 | −0.5% |
| Feb 2025 | −2.5% |
| May 2025 | −3.2% |
| Aug 2025 | −2.8% |
| Nov 2025 | −3.7% |
| Feb 2026 | −3.9% |
| May 2026 | −2.7% |
| Aug 2026 | −0.3% |
Profit, EPS
- Profit −132.8%
- EPS −300%
| Quarter | Profit | EPS |
|---|---|---|
| Nov 2023 | – | 16.5% |
| Feb 2024 | −124.7% | −91.4% |
| May 2024 | −197.2% | – |
| Aug 2024 | −300% | – |
| Nov 2024 | – | −300% |
| Feb 2025 | – | – |
| May 2025 | – | – |
| Aug 2025 | – | – |
| Nov 2025 | – | – |
| Feb 2026 | – | – |
| May 2026 | – | – |
| Aug 2026 | −132.8% | – |
ROCE: the return line, worked out each quarter
- ROCE −0.2%
| Quarter | ROCE |
|---|---|
| Nov 2023 | 3.1% |
| Feb 2024 | 3.1% |
| May 2024 | 1.4% |
| Aug 2024 | 0.9% |
| Nov 2024 | – |
| Feb 2025 | – |
| May 2025 | – |
| Aug 2025 | – |
| Nov 2025 | – |
| Feb 2026 | – |
| May 2026 | – |
| Aug 2026 | −0.2% |
Why it matters: with too little history, we say so rather than guess a direction.
One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.
There are fewer than eight usable quarters, so this page does not guess a direction from so little history.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | −2.7% | +1.9% | +13.2% | — |
| Stock price | +94.7% | −7.6% | −22.8% | −4.5% |
How much does Neogen earn on its capital?
Neogen Corporation earned a ROE of 0% in FY26. That is up from a low of −53% in FY25. Its return on capital used (ROIC) is 12.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.
Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.
It comes from a −0.9% net margin and 0.26× asset turnover (sales divided by assets).
Why the return is what it is (FY26): a −0.9% net margin × 0.26× asset turnover × 1.60× leverage (assets divided by equity) ≈ −0.4% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.
The key test, return on capital used minus the cost of capital: −0.3% − 12.2% = −12.5 percentage points. The 12.2% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.
FY26: ROE 0%, the climb back from FY25's −53%
- ROE −0.4%
- ROIC (annual) −0.8%
- Cost of capital 12.2%
| Quarter | ROE | ROIC (annual) | Cost of capital |
|---|---|---|---|
| FY21 | 7.2% | 14.3% | 12.2% |
| FY22 | 5.4% | 13.9% | 12.2% |
| FY23 | −0.7% | 1.7% | 12.2% |
| FY24 | −0.3% | 1.5% | 12.2% |
| FY25 | −52.7% | 0% | 12.2% |
| FY26 | −0.4% | −0.8% | 12.2% |
Aug 2026: ROIC −0.7% (last 12 months) against a 12.2% cost of capital
- ROIC (12 months) −0.7%
- ROE (12 months) −1.5%
- Cost of capital 12.2%
| Quarter | ROIC (12 months) | ROE (12 months) | Cost of capital |
|---|---|---|---|
| Nov 2023 | 4.1% | −6.4% | 12.2% |
| Feb 2024 | 3% | 1.6% | 12.2% |
| May 2024 | 2.9% | 0.2% | 12.2% |
| Aug 2024 | 1.5% | −1.2% | 12.2% |
| Nov 2024 | 1.1% | −3% | 12.2% |
| Feb 2025 | 0.8% | −65.5% | 12.2% |
| May 2025 | 0.7% | −66.8% | 12.2% |
| Aug 2025 | 0% | −169.6% | 12.2% |
| Nov 2025 | −0.6% | −161.1% | 12.2% |
| Feb 2026 | −0.9% | −101.2% | 12.2% |
| May 2026 | −1.2% | −102.8% | 12.2% |
| Aug 2026 | −0.7% | −1.5% | 12.2% |
Does Neogen have too much debt?
Neogen Corporation has total debt of $774 M against shareholder equity of $2.1 B as of Aug 2026, so its debt is 0.37× its equity. Year by year, that ratio went from 0.00 in FY21 to 0.39 in FY26. Keep that borrowing in mind when reading the returns on this page.
Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.
FY26: debt $813 M, 0.39× equity
- Total debt $813 M
| Quarter | Total debt |
|---|---|
| FY21 | $0 |
| FY22 | $3.2 M |
| FY23 | $902 M |
| FY24 | $906 M |
| FY25 | $914 M |
| FY26 | $813 M |
Debt-to-equity
- Debt-to-equity 0.39×
| Quarter | Debt-to-equity |
|---|---|
| FY21 | 0.00× |
| FY22 | 0.00× |
| FY23 | 0.29× |
| FY24 | 0.29× |
| FY25 | 0.44× |
| FY26 | 0.39× |
Aug 2026: debt $774 M, debt-to-equity 0.37
- Total debt (quarterly) $774 M
| Quarter | Total debt (quarterly) |
|---|---|
| Nov 2023 | $906 M |
| Feb 2024 | $907 M |
| May 2024 | $906 M |
| Aug 2024 | $895 M |
| Nov 2024 | $894 M |
| Feb 2025 | $894 M |
| May 2025 | $914 M |
| Aug 2025 | $795 M |
| Nov 2025 | $795 M |
| Feb 2026 | $795 M |
| May 2026 | $813 M |
| Aug 2026 | $774 M |
Debt-to-equity
- Debt-to-equity 0.37×
| Quarter | Debt-to-equity |
|---|---|
| Nov 2023 | 0.29× |
| Feb 2024 | 0.29× |
| May 2024 | 0.29× |
| Aug 2024 | 0.29× |
| Nov 2024 | 0.33× |
| Feb 2025 | 0.34× |
| May 2025 | 0.44× |
| Aug 2025 | 0.38× |
| Nov 2025 | 0.38× |
| Feb 2026 | 0.38× |
| May 2026 | 0.39× |
| Aug 2026 | 0.37× |
What is the Neogen shareholding pattern?
5.5% of Neogen Corporation's tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.
There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.
It is a single reading at one point in time; we do not have its history.
Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.
How far is Neogen from balance-sheet trouble?
For Neogen Corporation, the Z-score is 1.10. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
Why it matters: a Z-score of 1.10 is inside the danger zone, so the balance sheet is a real risk.
How does Neogen rank in its industry?
43.4 out of 100, rank 22 of 30 in Medical Devices, with 67% of the evidence available.
Neogen Corporation scores 43.4 out of 100 against the 30 companies it is compared with in Medical Devices, ranking 22. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
The four parts add up to the total exactly: 15.2 + 5.2 + 11 + 12 = 43.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Neogen compared with?
Neogen ranks 22 of 30 Medical Devices companies on the 4-Factor Sector Score, with 43.4 out of 100.
- 1DexCom, Inc.DXCM · turning · Most evidence points up · 81% evidence73.5out of 100
How the score adds up
Growth & earnings 28.0/35 · Revenue 15.5% · Profit 74.8% · Operating margin change 5.9 points · 83% evidenceCapital efficiency 20.9/25 · ROCE 27.8% · Operating margin 24.3% · 76% evidenceValuation 13.6/20 · P/E 26× · PEG 0.66 · 65% evidenceRelative strength 11.0/20 · Lead over its industry 1.7% · Lead over S&P 500 13.9% · 1 year 60.9% · 100% evidence · 11 of 12 weeks aheadExact sum: 28 + 20.9 + 13.6 + 11 = 73.5 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. - 2Globus Medical, Inc.GMED · turning · Most evidence points up · 81% evidence65.7out of 100
How the score adds up
Growth & earnings 28.0/35 · Revenue 19.8% · Profit 50.1% · Operating margin change 7.5 points · 83% evidenceCapital efficiency 17.6/25 · ROCE 14.6% · Operating margin 24.8% · 76% evidenceValuation 14.9/20 · P/E 20× · PEG 0.4 · 65% evidenceRelative strength 5.2/20 · Lead over its industry -13.9% · Lead over S&P 500 -3.6% · 1 year 3.8% · 100% evidence · 1 of 12 weeks aheadExact sum: 28 + 17.6 + 14.9 + 5.2 = 65.7 · What this means: Earnings are strong; relative strength in its sector is -13.9% and the one-year return is 3.8%. - 3Boston Scientific CorporationBSX · basing · Evidence leans up · 81% evidence61.3out of 100
How the score adds up
Growth & earnings 25.1/35 · Revenue 13.5% · Profit 46.7% · Operating margin change 4.3 points · 83% evidenceCapital efficiency 16.3/25 · ROCE 11.4% · Operating margin 22.9% · 76% evidenceValuation 15.6/20 · P/E 17.3× · PEG 0.37 · 65% evidenceRelative strength 4.3/20 · Lead over its industry -40.1% · Lead over S&P 500 -33.4% · 1 year -54.2% · 100% evidence · 0 of 12 weeks aheadExact sum: 25.1 + 16.3 + 15.6 + 4.3 = 61.3 · What this means: Earnings are strong; relative strength in its sector is -40.1% and the one-year return is -54.2%. - 4Haemonetics CorporationHAE · leader · Evidence leans up · 81% evidence59.0out of 100
How the score adds up
Growth & earnings 10.8/35 · Revenue 0.3% · Profit -40.5% · Operating margin change 0 points · 83% evidenceCapital efficiency 15.3/25 · ROCE 11.8% · Operating margin 17.9% · 76% evidenceValuation 13.3/20 · P/E 36.5× · PEG 0.49 · 65% evidenceRelative strength 19.6/20 · Lead over its industry 34.9% · Lead over S&P 500 50.5% · 1 year 86.4% · 100% evidence · 12 of 12 weeks aheadExact sum: 10.8 + 15.3 + 13.3 + 19.6 = 59 · What this means: Relative strength against the index is 50.5%, and revenue and profit growth are weak. - 5Insulet CorporationPODD · turning · Evidence leans up · 71% evidence58.6out of 100
How the score adds up
Growth & earnings 23.8/35 · Revenue 29.4% · Profit 58.6% · Operating margin change -2.5 points · 83% evidenceCapital efficiency 18.9/25 · ROCE 21.3% · Operating margin 16.2% · 76% evidenceValuation 9.3/20 · P/E 28.1× · PEG — · 15% evidenceRelative strength 6.6/20 · Lead over its industry -31.6% · Lead over S&P 500 -24% · 1 year -48.4% · 100% evidence · 1 of 12 weeks aheadExact sum: 23.8 + 18.9 + 9.3 + 6.6 = 58.6 · What this means: Earnings are strong; relative strength in its sector is -31.6% and the one-year return is -48.4%. - 6Glaukos CorporationGKOS · leader · Evidence leans up · 64% evidence56.8out of 100
How the score adds up
Growth & earnings 22.2/35 · Revenue 41.8% · Profit — · Operating margin change 9.8 points · 62% evidenceCapital efficiency 3.9/25 · ROCE -9.7% · Operating margin -8.5% · 76% evidenceValuation 11.2/20 · P/E -98.1× · PEG — · 15% evidenceRelative strength 19.5/20 · Lead over its industry 51.3% · Lead over S&P 500 69.3% · 1 year 194.2% · 100% evidence · 10 of 12 weeks aheadExact sum: 22.2 + 3.9 + 11.2 + 19.5 = 56.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 7STERIS plcSTE · turning · Evidence leans up · 81% evidence56.1out of 100
How the score adds up
Growth & earnings 20.2/35 · Revenue 8.3% · Profit 24.7% · Operating margin change 1.4 points · 83% evidenceCapital efficiency 15.4/25 · ROCE 12.2% · Operating margin 19.2% · 76% evidenceValuation 12.5/20 · P/E 25.5× · PEG 1 · 65% evidenceRelative strength 8.0/20 · Lead over its industry -10.4% · Lead over S&P 500 0.1% · 1 year -6% · 100% evidence · 4 of 12 weeks aheadExact sum: 20.2 + 15.4 + 12.5 + 8 = 56.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 8Stryker CorporationSYK · turning · Evidence leans up · 85% evidence55.8out of 100
How the score adds up
Growth & earnings 20.6/35 · Revenue 7.9% · Profit 23.1% · Operating margin change 0.7 points · 95% evidenceCapital efficiency 18.8/25 · ROCE 15.5% · Operating margin 23% · 76% evidenceValuation 10.4/20 · P/E 29.2× · PEG 1.25 · 65% evidenceRelative strength 6.0/20 · Lead over its industry -14.2% · Lead over S&P 500 -4% · 1 year -4.6% · 100% evidence · 1 of 12 weeks aheadExact sum: 20.6 + 18.8 + 10.4 + 6 = 55.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 9Medtronic plcMDT · breaking out · Evidence leans up · 85% evidence55.1out of 100
How the score adds up
Growth & earnings 19.1/35 · Revenue 9.8% · Profit 12.3% · Operating margin change 0.6 points · 95% evidenceCapital efficiency 14.3/25 · ROCE 9.4% · Operating margin 19.3% · 76% evidenceValuation 9.3/20 · P/E 20.9× · PEG 1.72 · 65% evidenceRelative strength 12.4/20 · Lead over its industry -2.8% · Lead over S&P 500 8.5% · 1 year 13.9% · 100% evidence · 9 of 12 weeks aheadExact sum: 19.1 + 14.3 + 9.3 + 12.4 = 55.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 10CONMED CorporationCNMD · turning · Evidence leans up · 81% evidence55.0out of 100
How the score adds up
Growth & earnings 14.7/35 · Revenue 3.4% · Profit -48.2% · Operating margin change 3.2 points · 83% evidenceCapital efficiency 11.5/25 · ROCE 8% · Operating margin 14.6% · 76% evidenceValuation 12.3/20 · P/E 17.4× · PEG 1.18 · 65% evidenceRelative strength 16.5/20 · Lead over its industry 8.5% · Lead over S&P 500 21.2% · 1 year 22% · 100% evidence · 11 of 12 weeks aheadExact sum: 14.7 + 11.5 + 12.3 + 16.5 = 55 · What this means: Relative strength against the index is 21.2%, and revenue and profit growth are weak. - 11Koninklijke Philips N.V.PHG · turning · Evidence leans up · 71% evidence53.6out of 100
- 12LivaNova PLCLIVN · turning · Evidence leans up · 64% evidence53.0out of 100
- 13Edwards Lifesciences CorporationEW · turning · Evidence leans up · 81% evidence51.7out of 100
- 14UFP Technologies, Inc.UFPT · leader · Evidence leans up · 81% evidence50.6out of 100
- 15Zimmer Biomet Holdings, Inc.ZBH · turning · Evidence leans up · 81% evidence50.0out of 100
- 16iRhythm Holdings, Inc.IRTC · turning · Evidence leans down · 64% evidence48.4out of 100
- 17Integer Holdings CorporationITGR · losing its lead · Too little evidence to rank firmly · 56% evidence48.3out of 100
- 18Smith & Nephew plcSNN · turning · Too little evidence to rank firmly · 51% evidence48.1out of 100
- 19Bruker CorporationBRKR · turning · Evidence leans down · 71% evidence47.7out of 100
- 20Butterfly Network, Inc.BFLY · quiet · Evidence leans down · 61% evidence47.7out of 100
- 21GE HealthCare Technologies Inc.GEHC · turning · Evidence leans down · 81% evidence46.9out of 100
- 22Neogen Corporation this pageNEOG · turning · Evidence leans down · 67% evidence43.4out of 100
How the score adds up
Growth & earnings 15.2/35 · Revenue -0.3% · Profit — · Operating margin change 6.9 points · 71% evidenceCapital efficiency 5.2/25 · ROCE -0.2% · Operating margin -0.8% · 76% evidenceValuation 11.0/20 · P/E -1.2× · PEG — · 15% evidenceRelative strength 12.0/20 · Lead over its industry 6.8% · Lead over S&P 500 19.6% · 1 year 94.7% · 100% evidence · 11 of 12 weeks aheadExact sum: 15.2 + 5.2 + 11 + 12 = 43.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 23Axogen, Inc.AXGN · turning · Evidence leans down · 64% evidence42.3out of 100
- 24Establishment Labs Holdings Inc.ESTA · basing · Evidence leans down · 61% evidence40.7out of 100
- 25Inspire Medical Systems, Inc.INSP · breaking out · Evidence leans down · 74% evidence39.8out of 100
- 26NovoCure LimitedNVCR · quiet · Evidence leans down · 61% evidence38.4out of 100
- 27Bio-Rad Laboratories, Inc.BIO · leader · Evidence leans down · 71% evidence38.1out of 100
- 28TransMedics Group, Inc.TMDX · quiet · Evidence leans down · 71% evidence36.3out of 100
- 29Abbott LaboratoriesABT · turning · Most evidence points down · 85% evidence34.5out of 100
- 30Penumbra, Inc.PEN · turning · Most evidence points down · 81% evidence32.9out of 100
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Medical Devices, all 30 compared on one page.
Which companies are close to Neogen in size?
Neogen is the 23rd largest of 75 Medical Devices companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: iRhythm Holdings, Inc., Integer Holdings Corporation and Axogen, Inc. Just below it: UFP Technologies, Inc., TransMedics Group, Inc. and Establishment Labs Holdings Inc.
Medical Devices companies close in size
- iRhythm Holdings, Inc. $4.4 billion
- Integer Holdings Corporation $4.3 billion
- Axogen, Inc. $3.1 billion
- Neogen Corporation $2.7 billion
- UFP Technologies, Inc. $2.6 billion
- TransMedics Group, Inc. $2.5 billion
- Establishment Labs Holdings Inc. $2 billion
All 75 Medical Devices companies, largest first
Companies close in size in other industries
- Stagwell Inc. $2.7 billion · Advertising Agencies
- AtaiBeckley Inc. $2.7 billion · Biotechnology
- Neogen Corporation $2.7 billion
- Patrick Industries, Inc. $2.7 billion · Recreational Vehicles
- Five9, Inc. $2.7 billion · Software - Infrastructure
What else do people ask about Neogen?
What were Neogen's latest quarterly results?
Neogen Corporation reported revenue of $223 M and a net loss of $11.9 M for the Aug 2026 quarter. Revenue rose 6.5% and profit fell 132.8% compared with a year earlier. Earnings per share were −$0.05.
The operating margin was −0.8%, 6.9 percentage points higher than a year earlier (as of 4 November 2026).
What is Neogen's market cap?
Neogen Corporation's market capitalisation is $2.7 B at a stock price of $12.46. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).
How is Neogen performing?
Neogen Corporation's share price has been rising for 28 weeks. In its latest quarter, revenue rose 6.5% and profit fell 132.8% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 4 November 2026).
Will Neogen's stock price go up?
This page does not forecast Neogen Corporation's stock price. What it shows instead: the stock price is $12.46, and it has been rising for 28 weeks. Its P/E of 5,023.3× is higher than 83% of its own last 3 years (as of 4 November 2026).
Is Neogen's profit real cash?
Yes, over the last 2 years, 137% of Neogen Corporation's reported profit came in as cash from operations. The latest year was lower at -1053%, so the trend is worth watching. In FY26, operating cash was $83.2 M against reported profit of −$7.9 M.
Most of that cash then goes into building new capacity. These are yearly figures (as of 4 November 2026).
Where is Neogen in its business cycle?
Neogen Corporation's FY26 operating margin was −2.5%, against a 6-year range of −2.5% to 16.0%: the low end of its own range, which is often where recoveries start. The latest quarter was −0.8%.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).
What could break the Neogen story?
The main question: results are strong, and the P/E is higher than 83% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).
Is Neogen a stock worth studying right now?
What the numbers show: Neogen Corporation's results are improving, and its P/E is near the top of its own history, higher than 83% of past readings. The main open question: whether earnings grow enough to match the multiple.
Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
US stocks
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.